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Abstract 
Aims and Objectives. This study aimed to describe auditory characteristics and balance 
function in patients with diabetes between 18-55 years of age as well as determine the 
association between patients’ auditory and balance function with diabetes characteristics (type, 
duration and control).  
Background. Diabetes is one of the most prevalent non-communicable diseases worldwide 
with approximately 422 million people diagnosed globally. This number is projected to rise to 
642 million by 2040 if no appropriate interventions are implemented to reverse the rise in the 
number of people with diabetes. South Africa has the second highest diabetes prevalence in 
Africa (after Nigeria) with 2.6 million cases.  
A rise in diabetes prevalence should be a concern for audiologists with increasing literature 
linking diabetes with the risk of acquiring hearing and balance disorders. However, there is 
currently a lack of research done in South Africa to investigate auditory and balance disorders 
in patients with diabetes. Therefore, the current study sought to investigate auditory 
characteristics and balance function in South African patients diagnosed with diabetes. It is 
anticipated that the study findings will yield evidence that will highlight the role of an 
audiologist in the clinical management of patients with diabetes. 
Research Design. The study utilised an observational cross-sectional matched groups design 
with a cohort (patients with diabetes) and control (volunteers without diabetes) group of 
participants. Participants were recruited from a Primary Health Care clinic in Polokwane, 
Limpopo using purposive and convenience sampling for the cohort and control group 
respectively. 
6 
Methodology. Several methods were used to collect data pertinent to this study. These included 
case history interview and a medical folder review to obtain information related to participants’ 
diabetes status. Furthermore, all participants underwent the following assessments: otoscopy, 
pure tone audiometry, diagnostic distortion product otoacoustic emissions (DPOAE), vision 
screening, peripheral neuropathy screening, Dynamic Gait Index test (DGI) and the Modified 
Clinical Test of Sensory Integration (MCTSIB). Data were analyzed using both descriptive and 
inferential statistical tests.  
Results. A total of 192 participants took part in this study; 110 in the cohort and 82 in the 
control group. There were similar distributions of gender in both groups with the following age 
distributions (in years) for each group; cohort; median =46, range =20-55, control; median 
=43, range =21-55. Pure tone audiometry assessments showed a significantly higher 
prevalence of hearing loss in the cohort (55%) when compared to the control (20%) group (p < 
.001). Participant age, gender and diabetes duration were associated with the likelihood of 
having hearing loss (age: odds ratio=2.90, 95% CI: 1.19-7.08, p=0.019; gender (male): odds 
ratio=.266, 95% CI: .104-.677, p=0.005; diabetes duration: odds ratio=1.12, 95% CI: 1.02-
1.22, p=0.013). DPOAE assessments showed significantly higher percentages of abnormalities 
with signal to noise ratio (p < 0.01) and DPOAE level (p < 0.01) in the cohort compared to the 
control group. A significantly higher proportion (38%) of participants in the cohort group 
reported tinnitus when compared to 15% in the control (p < .001). Balance screening 
assessments with the DGI and the MCTSIB, showed significantly poorer performance in the 
cohort group than the control (DGI:, p < .001; MCTSIB: p < .001). 
Conclusion. Overall findings of this study showed that participants who were diagnosed with 
diabetes had a higher proportion of auditory and balance abnormalities when compared to those 
in the control group. Older age, male gender and longer duration since diabetes diagnosis were 
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associated with a higher likelihood of having hearing loss.  The findings of this study therefore 
suggest that auditory and balance dysfunction should be considered as comorbidities associated 
with diabetes. This study also highlighted the role of an audiologist in the managment of 
patients with diabetes with respect to early identification and management of auditory and 
balance dysfunctions amongst these patients.  




Key Abbreviations:  
cPTA- Conventional Pure Tone Average 
CI: Confidence Interval. 
dB HL- Decibel Hearing Loss 
dB SPL- Decibel Sound Pressure Level 
DGI- Dynamic Gait Index 
DPOAE- Distortion Product Otoacoustic Emissions 
DNS- Diabetic Neuropathy Score 
DoH- Department of Health 
HF-PTA- High frequency Pure Tone Average 
IDF- International Diabetes Federation 
MCTSIB- Modified Clinical Test of Sensory Integration and Balance 
NCD- Non-communicable Diseases 
OR- Odds ratio 
PTA- Pure tone average 
SNR- Signal to Noise Ratio 
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Chapter 1: Introduction 
 
Introduction: This chapter will provide the study background by presenting global and 
local prevalence reports of non-communicable diseases, with emphasis on the prevalence of 
diabetes in Africa and South Africa. Associations between diabetes, hearing loss and balance 
dysfunction will also be introduced to provide the study rationale.  
Prevalence of non-communicable diseases 
The prevalence of non-communicable diseases (NCDs) such as diabetes, is expected to 
surpass that of the current predominant communicable (infectious) diseases in the next 20 years 
(World Health Organization [WHO], 2012; Mendis & Chestnov, 2013). NCDs are recognised 
as a significant burden on the health systems and economies globally, particularly in 
developing nations (Boutayeb & Boutayeb, 2005). Collectively, NCDs are responsible for an 
estimated 38 million deaths per year globally and almost three quarters of the deaths occur in 
low and middle income countries (Mendis & Chestnov, 2013; WHO, 2015). African countries 
are expected to have the world’s largest increase in NCDs morbidity and mortality over the 
next decade (Naik & Kaneda, 2015). In South Africa, the burden of NCDs currently accounts 
for up to 700 in every 100 000 deaths (Chopra et al., 2009; Distiller, 2004; Mathee, 2011; 
Mayosi et al., 2009, 2012).  
Diabetes, which was the focus of this study, is one of the most prevalent non-
communicable diseases and has become a worldwide epidemic (Frisina, Mapes, Kim & Frisina, 
2006; Rheeder, 2006). It is a metabolic disorder characterized by chronic hyperglycaemia 
resulting from defects in insulin secretion, insulin action, or both (International Diabetes 
Federation, [IDF] 2015). There are three types of diabetes; Type 1 (insulin dependent), Type 2 
(non-insulin dependent), and gestational diabetes which occurs during pregnancy (Tuomi, 
2005; Drouin et al., 2009). Current estimates show that as of 2014, 422 million people above 
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18 years of age, have diabetes and this number is projected to reach 642 million by 2040 (WHO, 
2016). It is also estimated that up to 192 million people worldwide are living with undiagnosed 
diabetes (IDF, 2015). Global mortality rates show that 5 million people between 20 and 79 
years of age died from diabetes and diabetes related complications, compared to only 3.6 
million that died from Human Immunodeficiency Virus (HIV), Tuberculosis (TB) and malaria 
combined in 2015 (IDF, 2015). 
The African continent has up to 25 million people living with diabetes along with the 
highest proportion of undiagnosed adults under 60 years of age (WHO, 2016). The existence 
of diabetes in Africa was once a rare occurrence, however the prevalence is rapidly rising with 
numbers estimated to continue to increase by 110% in the region (Peer, Kengne, Motala & 
Mbanya, 2013). South Africa has one of the highest and fastest growing diabetes prevalence 
numbers in Africa with more than 2 million people living with diabetes (Peer et al., 2013).  
Factors contributing to the  increasing prevalence of diabetes in Africa include growing 
urbanization, increases in economic development, life expectancy and the worldwide rise in 
obesity (Levitt 2008; Peer et al., 2013). There is evidence that urbanization and economic 
development have been linked to the increase in diabetes prevalence owing to the change in 
lifestyle (more sedentary) and diet (more processed foods), hence diabetes was termed “the 
disease of opulence” (Sherif & Sampio, 2015; Azevedo & Alla, 2008). Africa is already 
burdened with communicable diseases, for example,  HIV, Acquired Immunodeficiency 
Syndrome (AIDS) and high rates of TB (Lam & LeRoith, 2012; Levitt, 2008; Peer et al., 2013). 
Therefore, the rise of NCDs in developing regions add a significant burden to already under-
resourced public health budgets (Mayosi et al., 2009).   
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Diabetes, hearing loss and balance dysfunction 
The projected epidemiological trends of diabetes suggest that it is likely to be a 
significant contributor to the burden of disease globally, especially in developing countries. 
This is a major concern for hearing health care professionals because there is an emerging body 
of research evidence that associates diabetes with the risk of developing auditory and balance 
dysfunctions (Kakarlapudi, Sawyer, & Staecker, 2003; Panchu, 2008; Pemmaiah & Srinivas, 
2011; Thimmasettaiah & Shankar, 2012). Thus an increase in the prevalence of diabetes may 
potentially lead to an increase in the burden of auditory and balance dysfunctions (Pemmaiah 
& Srinivas, 2011).  
At present, research evidence linking diabetes with auditory and balance dysfunctions 
is not extensive, however the reported association has moved from uncertain to plausible 
(Jáuregui-Renaud, Sánchez, Olmos, & González-Barcena, 2009; Panchu, 2008; Pemmaiah & 
Srinivas, 2011; Thimmasettaiah & Shankar, 2012). This plausibility was based on pathological 
anatomical changes observed in post-mortem investigations of patients with diabetes revealing 
damage to the vasculature and neural system of the inner ear (Bainbridge, Hoffman,  & Cowie, 
2008; Botelho, Carvalho, & Silva, 2014; Frisina et al., 2006; Lisowska, Namysłowski, 
Morawski & Strojek, 2001). Abnormalities observed include thickening of capillaries in the 
stria vascularis, atrophy of the spiral ganglion, narrowing of the internal auditory artery and/or 
demyelination of the eighth cranial nerve (Bainbridge et al., 2008; Frisina et al., 2006; 
Lisowska et al., 2001). The inner ear and its associated neural systems have complex 
components and arrangement that requires glucose and high-energy for the intricate 
functioning involved in hearing and balance functioning (Frisina et al., 2006). Therefore, 
complications of hyperglycaemia can result in physiological disturbances that affect auditory 
and balance functions in patients with diabetes (Botelho et al., 2014; Drouin et al., 2009). 
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Hearing loss reported amongst patients with diabetes include sensorineural, conductive 
and mixed hearing losses (Pemmaiah & Srinivas, 2011). Several plausible explanations for the 
presence of sensorineural hearing loss in patients with diabetes as discussed by Akbar (2016) 
include: microangiopathy, neuropathy, and genetic mutation in mitochondrial DNA. Presence 
of mixed and conductive hearing losses in patients with diabetes may be explained by the 
increased susceptibility to middle and outer ear pathologies due to their compromised immune 
systems, especially in those with comorbidities (Thimmasettaiah & Shankar, 2012).  
Hearing loss is already a major public health issue globally with adult-onset hearing 
loss ranked second highest contributor to years lost to disease (Olege & Okorot, 2005; Bagli, 
2012). Hearing loss (regardless of the aetiology), can have a negative impact on an individual’s 
physical, cognitive, behavioural, and social functions, as well as general health-related quality 
of life (Bagli, 2012; Mozaffari, Tajik, Ariaei, Ali-Ehyaii& Behnam, 2010; Danermark et al., 
2010). For example, hearing loss has been associated with dementia as well as difficulties in 
employment acquisition and retention with up to 11% of adults changing their job due to their 
hearing loss (Lin et al., 2011; Shield, 2005). Therefore, the potential increase in hearing loss 
prevalence among patients with diabetes is a concern for hearing health professionals, the 
public health system as well as the economy (Shield, 2005). 
Diabetes has also been associated with deterioration in balance function. The most 
common balance disorders reported in patients with diabetes include unsteady gait and 
increased risk for falls (Agrawal, Carey, Schubert & Minor, 2009). D’Silva, Lin, Staecker, 
Whitney and Kluding (2016) suggested that balance deficits are due to multi-organ structural, 
and functional changes due to diabetes related microvascular complications such as lower limb 
peripheral neuropathy and retinopathy.  
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Balance dysfunction can also have a negative impact on an individual because of its 
effect on quality of life. Activity restrictions, decreased social participation, and an increased 
need for sick leave may occur in up to 80% of affected patients visiting the doctor’s office due 
to balance disorders (Agrawal et al., 2013; Sturnieks, St George, & Lord, 2008). In addition, 
balance dysfunctions can have social impacts which include disruption of social life, family 
difficulties, and challenges with travel (Agrawal et al., 2013). A study by Formiga et al. (2015) 
further demonstrates that balance dysfunction can result in falls and accidental injuries. 
According to the WHO (2012) factsheet, falls and unstable gait are the second leading cause 
of unintentional injuries worldwide.  
Therefore, an increase in the burden of diabetes should be a concern for audiologists 
and it is against this backdrop that the current study was conducted to document auditory 
characteristics and balance function in patients with diabetes in South Africa as a country with 




Chapter 2: Literature Review 
Introduction: In this chapter, literature linking diabetes with hearing and balance 
dysfunction will be critically reviewed. Existing gaps in literature specific to diabetes related 
dysfunctions in hearing and balance will be highlighted and justification regarding the need for 
this study will also be presented.  
Hearing loss and diabetes 
There is some research evidence supporting the association of hearing loss in patients 
with diabetes (Ramma & Sebothoma, 2016; Thimmasettaiah & Shankar, 2012; Pemmaiah & 
Srinivas, 2011; Ologe & Okoro, 2005; Lisowska et al., 2001). In Poland, Lisowska, et al. 
(2001), in a cross-sectional study involving patients with Type 1 diabetes (n=42) reported 
peripheral and central disturbances of the auditory pathway which lead to subsequent 
sensorineural hearing loss. A similar study by Pemmaiah and Srinivas (2011) (n=110), 
conducted in India, reported a statistically significant correlation between hearing loss and 
diabetes. In Africa, Ologe and Okoro (2005) in their matched cross-sectional study (n=105) 
reported that middle-aged adults in Nigeria with Type 2 diabetes are more likely to have 
hearing loss than their nondiabetic compatriots of a similar age. In South Africa, a cross-
sectional survey by Ramma and Sebothoma (2016) (n=2494) reported diabetes as one of the 
factors associated with hearing loss.  
However, there are considerable regional differences in prevalence reports of hearing 
loss amongst patients with diabetes, with prevalence ranging between 13-78% (Kakarlapudi et 
al., 2003; Mozaffari et al., 2010; Bhaskar, Chalihadan, Vaswani & Rehaman, 2014). In the 
United States of America, Kakarlapudi et al. (2003) (n=12575) reported 13.1% hearing loss 
prevalence; in contrast, Mozaffari et al. (2010) (n=160) in Iran, reported a higher prevalence 
of 45%. Most recent, Srinivas, Shyamala and Shiva Kumar (2016) documented a 66% 
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prevalence of sensorineural hearing loss in their study (n=50). The highest prevalence was 
reported in India by Bhaskar et al., (2014) (n=107) with 78.2% prevalence of sensorineural 
hearing loss in their study. There are several factors that may help explain this variation in the 
prevalence of hearing loss reported in previous studies. These include differences in study 
designs, sample sizes, and hearing loss assessment methods carried out to determine 
prevalence.  
In terms of study design, Kakarlapudi et al. (2003) utilised a retrospective medical 
folder review design and their low prevalence finding (13.1%) could have been due to common 
drawbacks associated with their study design, e.g. missing information in folders. In terms of 
sample size, it was noted that a study by Bhaskar et al. (2014) which had the smallest sample 
of participants with diabetes (n=57) of the studies reviewed for this study, reported the highest 
hearing loss prevalence (78.2%). With hearing loss assessments administered in previous 
studies, there were key factors identified that impacted prevalence reports. These included the 
classification of hearing loss in terms of hearing level norms (in dB HL), pure tone average 
(PTA) calculation, and the type of assessments used.  
 First, the classification of hearing loss in terms of the cut-off threshold used to 
distinguish between presence or absence of hearing loss may have influenced prevalence 
reports. Presence of hearing loss is determined using pure tone hearing thresholds (measured 
in decibels, dB HL) with  25 dB HL as the typical cut-off used to differentiate between presence 
or absence of hearing loss (in adults) (WHO, 2015). However, there are other cut-off thresholds 
that can be used to classify presence and degree of hearing loss, e.g. Clark’s (1981) cut-off of 
15 dB HL. The prevalence of hearing loss reported will therefore vary depending on which one 
of these two cut-offs is used. For instance, hearing loss prevalence of 70% was reported by 
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Agarwal et al., (2013) using a 15 dB HL as a cut-off whereas, Thimmasettaiah and Shankar, 
(2012), reported a lower hearing loss prevalence of 42% using 25 dB HL as a cut-off.   
 Second, the frequencies used to determine the PTA can also influence the prevalence 
of hearing loss reported. In most clinical settings, a PTA is derived using three frequencies that 
cover the low to mid ranges (0.5, 1 and 2 kHz), however diabetes related hearing loss first 
affects the high frequencies between 2 and 8 kHz, (Mozaffari et al., 2010; Pemmaiah & 
Srinivas, 2011). Thus, variable prevalence reporting may also be accounted for depending on 
the PTA calculation researchers utilise to classify hearing loss in patients with diabetes. In 
order to observe possible diabetes related hearing loss with PTA calculations that are inclusive 
of higher frequencies, some studies have added modified PTA calculations. For instance, 
Mitchell, Gopinath, McMahon, Wang, and Leeder (2009) and Mozaffari et al. (2010) used a 
PTA with frequencies (0.5, 1, 2 & 4 kHz) and Helzner et al. (2011) used a specific high 
frequency PTA (HF-PTA) (2, 4, & 8 kHz). The impact of the different PTA calculations on 
hearing loss prevalence is demonstrated by Samelli et al. (2017) in their study with their 
findings showing a higher prevalence of hearing loss within the higher frequencies than the 
lower frequencies.  
Third, the type of assessments used to establish diabetes related auditory dysfunction 
can also impact on the prevalence findings reported. Most studies that have investigated the 
presence of auditory abnormalities in diabetes patients used pure tone audiometry assessment 
in the standard frequency range (250-8000 Hz) (Panchu, 2008; Pemmaiah & Srinivas, 2011;). 
Pure tone audiometry may not be sufficiently sensitive to detect diabetes related damage 
therefore, the addition of otoacoustic emissions (OAEs) as part of the test battery was 
recommended to cross check of findings with an objective and sensitive assessment of the 
diabetes related damage to the auditory pathway (Botelho et al., 2014). OAEs assess  cochlear 
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function, specifically the outer hair cells, with objective monitoring of dynamic changes in 
cochlea responsiveness before functional and significant hearing loss occur (Hamed & El-attar, 
2010). While OAEs do not test hearing acuity as such, the assessments give valuable 
information about the site of lesion by differentiating between sensory abnormalities, that may 
be due to diabetic microvascular damage to the cochlea (Sanju & Kumar, 2015), and a neural 
abnormality. Therefore, considering the variations in the current literature as identified above, 
the current study design was selected to avoid the methodological shortfalls of previous studies.  
Tinnitus and diabetes  
Tinnitus refers to a perception or awareness of sound in the ears in the presence or 
absence of an external source (Negrila-Mezei, Enache & Sarafoleanu, 2011). McCombe and 
colleagues (2001) reported that up to a third of the normal adult population experience tinnitus 
in their lifetime. However, only one in ten of those affected by tinnitus will report an impact to 
their quality of life and negatively impact psychosocial well-being (Kenny, 2014; Negrila-
Mezei et al., 2011).  
There is currently no known single cause for tinnitus, however many possible 
aetiologies have been suggested including but not limited to: hearing loss, metabolic diseases, 
inner ear hair cell loss, stress, head injury, and ototoxic medication (Negrila-Mezei et al., 2011; 
McCombe et al., 2001, Gopinath et al., 2009). Akkuzu, Yilmaz, Cakmak and Ozluoglu (2004) 
describe that tinnitus incidence rises with age. With tinnitus prevalence, adults 30 years and 
above show a 7% prevalence whilst those 80 years and above showing up to 21% prevalence 
(Akkuzu et al., 2004). Although tinnitus affects many secondarily, it can be a clinical problem 
on its own for some.  
Gibrin, Melo and Marchior (2012) reported an increased risk of tinnitus occurrence in 
patients with diabetes. Prevalence of tinnitus in patients with diabetes in their study was found 
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to be 43% (n= 519) (Gibrin et al., 2012). Furthermore, findings from their study showed a 
twofold increased risk of tinnitus in patients with both diabetes and hypertension (Gibrin et al., 
2012). Akkuzu et al. (2004) explained the presence of tinnitus in patients with diabetes could 
be due to the observed macro-vascular damage in the inner ear of these patients as well as 
medication used to treat diabetes. Lacking in literature reviewed, are studies investigating the 
presence of tinnitus along with hearing loss in the same sample of patients with diabetes.  
Balance dysfunction and diabetes 
Balance is the perception of orientation and postural stability that depends on the 
integration of visual, somatosensory and vestibular information, with motor responses 
(Salsabili, Bahrpeyma, Forogh, & Rajabali, 2011). Yim-Chiplis and Talbot (2000) stated that 
the ability to maintain balance is the foundation for mobility and overall functional 
independence throughout the lifespan. A balance dysfunction is a disturbance with the 
integration of visual, somatosensory, and vestibular information that causes an individual to 
feel unsteady, having a sensation of movement, spinning, or floating (Walley, Anderson, 
Pippen & Maitland, 2014). Balance dysfunction can be debilitating and may lead to 
catastrophic outcomes such as falls (Agrawal et al., 2009). Fall risk is the probability and or 
potential threat for an individual to have a fall influenced by certain intrinsic and extrinsic 
factors (Cheng & Luo, 2015). 
Balance dysfunctions resulting in falls are the third leading cause of unintentional 
deaths in homes and communities, and the leading cause of unintentional injuries (Maurer, 
Burcham & Cheng, 2005). An individual’s chance of falling is described as fall risk, which is 
derived from a combination of extrinsic and intrinsic factors (Cheng & Luo, 2015). The more 
intrinsic factors someone has, and these include poor balance, diabetes, neuropathies, and 
arthritis, the greater the risk of falling (Salsabili et al., 2011; Walley et al., 2014). Maurer and 
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colleagues (2005) indicated that there are major health and economic burdens that come with 
balance dysfunction resulting in falls and suggest prevention and early diagnosis can relieve 
both the affected patient population and the public health system.  
A systematic review by D’Silva et al. (2016) reported on numerous studies that present 
evidence of the link between diabetes and balance dysfunction (Gawron et al., 2002; Agrawal 
et al., 2010; Salsabili et al., 2011; Yoda et al., 2011). Agrawal et al. (2010) reported balance 
dysfunction to be 70% higher in people with diabetes than those without. Similar findings were 
reported by Juregui-Renaud and colleagues (2009) in their cross-sectional matched groups 
survey (n=202) in which they established that patients with diabetes showed a higher frequency 
of dizziness (49%); instability when changing posture (43%), and instability when walking on 
uneven surfaces (38%). Maurer, Burcham and Cheng (2005), using a prospective cohort of 
patients with diabetes (n=139) found that 78% of their study participants had balance disorders 
which resulted in falls.  
Although there is evidence in literature for balance dysfunction leading to fall risk in 
patients with diabetes, there were several shortcomings identified in a review of the literature. 
Some of the previous studies had several methodological limitations that make it difficult to 
associate the balance dysfunction identified in these patients to diabetes. Some of the 
noteworthy methodological limitations include use of elderly participants; use of 
subjective/self-rating questionnaires, use of inappropriate assessment procedures as well as 
lack of interrogation of how multiple sensory deficits that are highly prevalent in these patients 
impact their balance function and susceptibility to falls. 
First, in terms of the age group of participants in previous studies, most studies 
investigating balance dysfunction in patients with diabetes focused on the elderly population 
which is a limitation as this population may already be predisposed to fall risk because of age 
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related deterioration (Maurer et al., 2005; Walley et al., 2014; Formiga et al., 2015; Wilson, 
Garner & Loprinzi, 2016; Wrisley & Kumar, 2016).  
The second and third drawbacks in previous balance studies with patients diagnosed 
with diabetes are in relation to the assessments that investigators used. In a systematic review 
by D’Silva et al. (2016), there were studies that utilized subjective patient questionnaires as 
assessments to determine balance dysfunction. This is a limitation as subjective assessments 
are open to be influenced by the patient’s understanding, interpretation and weighting of their 
symptoms which may have been avoided by using objective clinician assessments. Also, other 
studies like that of Agrawal and colleagues (2010) with the National Health and Nutrition 
Examination Survey in America, used the modified Romberg test to assume vestibular function 
and fall risk in patients with diabetes. This is a limitation because according to Jacobson et al. 
(2011) the Romberg test has poor sensitivity and specificity to determine vestibular 
dysfunction.  
Finally, Wilson et al. (2016) and Walley et al. (2014), noted the lack of research 
evidence in terms of how multiple sensory impairments affect balance and fall risk especially 
in patients with diabetes. This is important as hearing and vision deficits influence balance and 
increase fall risk (Walley et al., 2014). Therefore, research focusing on screening and 
assessment of balance in terms of predicting fall risk among patients with diabetes is needed to 
bridge the gap in literature (D’Silva et al., 2016; Ozel, Ozkiris, Gencer, & Saydam, 2014). 
Diabetes related versus comorbidity-related dysfunctions 
The challenge in establishing an association between diabetes with auditory and balance 
dysfunction has been that most of diabetes comorbidities are also risk factors for both hearing 
loss and balance dysfunction on their own (Chang et al., 2011; Chao, 2004). For instance, 
hypertension, peripheral neuropathy, retinopathy, and age related deterioration which are 
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common diabetes co-morbidities are also reported in literature as risk factors for acquiring 
hearing loss and balance dysfunction (Bainbridge et al, 2008; Chang et al., 2011).  
Specific to hypertension, adverse synergistic effects were observed with microvascular 
damage in the inner ear that is similar to diabetes related damage (Chang et al., 2011; Chao, 
2004; Kakarlapudi et al, 2003). This is important to note because the prevalence of 
hypertension in patients with diabetes varies between 10% and 80%, (Kakarlapudi et al., 2003). 
Unfortunately, most of the previous studies did not investigate whether the presence of 
hypertension increased the risk for auditory and balance dysfunction in patients with diabetes.  
Specific to peripheral neuropathy and retinopathy, both increase a patient’s 
susceptibility to balance dysfunction (Rubenstein, 2006, D’Silva et al., 2016). Agrawal, Ward 
and Minor (2013) elaborate that balance dysfunctions in patients with peripheral neuropathy 
and/or retinopathy include postural instability, gait disturbances, syncope, and dizziness. 
Existing literature also indicates that peripheral neuropathy and retinopathy impact the sensory 
inputs from vision and gravity from lower limbs, which are both necessary for postural stability 
and balance (D’Silva et al., 2016; Agrawal et al., 2010). Therefore, balance assessments in 
patients with both diabetes and retinopathy or peripheral neuropathy, should consider the added 
impact of the comorbidities to the patient’s balance function. Rubenstein (2006) recommended 
that vision and neuropathy screening be added with balance assessments in at risk populations 
such as patients with diabetes. However, most studies that investigated balance dysfunction in 
patients with diabetes did not screen for retinopathy and peripheral neuropathy to document 
the assumed increase in risk. 
Other factors (besides diabetes) have also been identified in previous studies to explain 
the presence and or exacerbation of auditory and balance dysfunction in people with diabetes. 
These include family history of hearing loss, smoking, exposure to ototoxic drugs, cancers, 
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other cardiovascular diseases, occupational noise exposure, head injuries as well as alcohol, 
and age related deterioration  (Pemmaiah & Srinivas, 2011). However, these factors are not 
specific to diabetes and can affect even those without diabetes. For example, there is a 
consensus regarding the negative impact of increasing age to hearing and balance function, 
independent of diabetes presence (Kakarlapudi et al., 2003; Pemmaiah & Srinivas, 2011; 
Thimmasettaiah & Shankar, 2012; Sturnieks et al., 2008).  
Study rationale 
There are several studies that investigated the impact of the communicable diseases 
such as HIV/AIDS and TB on audiological and balance functions in developing countries like 
South Africa  (Flower, 1991; Harris et al., 2012; Khoza & Ross, 2002; Khoza-Shangase, 2010a, 
2010b). However, not much research has focused on NCDs and their impact on audiological 
and balance functioning. Diabetes is one of the most prevalent NCDs, and projections show 
that its prevalence is expected to increase. South Africa has the second highest diabetes 
prevalence in the continent with over 2 million people diagnosed with diabetes (WHO, 2016). 
What is of concern to audiologists is the emerging body of research that associates diabetes 
with auditory and balance dysfunctions. However, as discussed in the literature review above, 
there is currently lack of conclusive research literature evidence that confirms a clear 
association between diabetes, auditory and balance dysfunctions. There is also limited research 
from developing countries such as South Africa investigating this association between diabetes 
and dysfunctions in auditory and balance systems, hence this study.  
 It is anticipated that outcomes of the study will be used to obtain information to answer 
some of the unanswered questions as well as inform health promotion with respect to the need 
for auditory and balance screening in patients with diabetes and highlight the role of 
audiologists in diabetes care.  
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Chapter 3: Methodology 
 
Introduction: This chapter will outline the aims, objectives, methodological aspects as 
well as ethical considerations for the study. Last, the chapter will outline how the data obtained 
in the study was analysed.  
Aims and objectives 
The aim of this study was to describe the audiological characteristics and balance 
function in patients with diabetes between 18-55 years of age and compare findings with a 
group of individuals without a diabetes diagnosis (control group). The objectives of the study 
were to: 
1. Determine the proportion of patients diagnosed with diabetes who: 
a. Present with abnormal audiometric findings: as determined through hearing levels 
using pure tone audiometry and outer hair cell function using distortion product 
otoacoustic emissions (DPOAE) 
b. Reported tinnitus: as determined through participant self-report during case history. 
The presence or absence of tinnitus was based on participants’ subjective reports of 
any ringing, whooshing, thumping sound in the ear without the presence of an 
external sound source at any time (Negrila-Mezei et al., 2011).    
c. Present with abnormalities in balance function: as determined by screening for fall 
risk through 
i. Screening static balance: postural stability screened with the Modified Clinical 
Test of Sensory Integrationof Balance (MCTSIB). 
ii. Screening dynamic balance: fall risk screened with the Dynamic Gait Index 
(DGI).   
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2. Describe the characteristics of hearing loss, tinnitus and balance function in patients 
with diabetes   
3. Determine the associations between the hearing loss, tinnitus and balance function with 
the following characteristics of diabetes mellitus: 
a. Type ( type I, type II) 
b. Duration of disease (in years) 
c. Glycemic status (last reading in g/mol as determined by the doctor and 
documented in patient file)  
d. Demographics of  age and gender.  
e. Co-morbidities: 
i. Hypertension: presence or absence as reported in patient files  
ii. Peripheral neuropathy: determined through screening with the diabetic 
neuropathy symptoms (DNS) score. 
iii. Retinopathy: determined through screening with a visual screening chart. 
Research design 
This study employed an observational cross-sectional matched groups design. The 
study design was an observational cross-sectional design as the variables of interest were 
measured at one point in time and the researcher had no influence and/or intevention to the 
study variables (Hartung & Touchette, 2009; Morrow, 2010). Observational cross-sectional 
designs are best suited to determine prevalence of a variable of interest, which in this study 
were hearing loss and balance function (Hartung & Touchette, 2009; Mann, 2003; Morrow, 
2010). The drawback of a cross-sectional study design include the inability to determine cause 
and effect, however, with a cross-sectional design, relationships between variables can be 
determined using this type of design. (Hartung & Touchette, 2009). Matched group designs are 
used in research to ensure comparability as well as reducing variability and systematic 
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differences due confounding variables (Song & Chung, 2010). The two groups used in this 
study comprised participants diagnosed with diabetes (Cohort) and another group consisting of 
participants without a diagnosis of diabetes (Control). Participants in both groups were matched 
for age and gender to allow for comparison between the two groups. Advantages of a matched 
group design include eliminating the influence of age and gender which are often the strong 
confounding variables (Song & Chung, 2010). 
Sampling method 
Participants in the cohort group were purposively sampled to ensure that only those 
who meet the eligibility criteria participate. A convenience sampling strategy was used to select 
participants for the control group as they readily made themselves available to the researcher 
(Mann, 2003). The non-probability sampling frames that were used for both participant groups 
are advantageous in that less time constraints, and overall fewer costs are implied (Palys, 2008). 
A major disadvantage of non-probability sampling is the inability to generalize findings 
compared to probability sampling (Kar & Ramalingam, 2013). 
Sample Size 
The sample size required for this study was determined using a G-Power analysis 
calculator (Faul, Erdfelder, Buchner & Lang, 2009). With a power of 0.95 and an error 
probability of 0.05, the sample size required for this study was 222 individuals; 111 participants 
per group (Faul et al, 2009). (see Table 1).  
Previous studies had sample sizes ranging between 80 and 220 participants and were 
determined to have sufficient power (Mozaffari et al., 2010; Pemmaiah & Srinivas, 2011). 




Table 1  
Sample size calculation. 
Analysis Required sample size  
Input Tails One 
 Error probability 0.05 
 Power 0.95 
Output Non-centrality parameter 
Critical t 
Df 





 Actual Power 0.9901086 
All participants (cohort and control) were selected to participate in this study based on 
the following inclusion and exclusion criteria: 
Inclusion criteria:  
 Clinically confirmed diagnosis of diabetes of either type (only for cohort group) 
 Above the age of 18 and below 55 years of age. The upper limit of 55 years was selected 
in order to avoid impact of age related deterioration (> 55 years) to both the auditory 
and balance functions (Bagli, 2012). The lower limit of 18 years was selected in order 
to target only adults to participate in the study and avoid special consent and assent 
which is required for individuals < 18 years old. A similar age range was used in a study 
by Panchu (2008) for the same rationale.  
Exclusion criteria (established through case history):  
 No exposure to loud recreational or occupational noise (24 hours prior testing) to avoid 
a temporary threshold shift (Franz & Phillips, 2001). 
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 No prior use of ototoxic drugs to avoid ototoxicity and vestibulotoxicity that might
result in either hearing or balance dysfunction (Akinpelu, Ibrahim, Waissbluth &
Daniel, 2014). History of all medication taken was documented in the patient files.
 No history of head injury, radiotherapy to the head or ear surgery as either may affect
hearing or balance functions (Low, Toh, Wee, Fook-Chongand & Wang, 2006).
 No clinical diagnoses or reports of neurological impairments that can affect balance
such as multiple sclerosis, cerebrovascular accidents (ischemic and hemorrhagic
strokes), Parkinson’s disease and ataxia (Neuhauser et al, 2005).
Recruitment of participants 
Cohort Group: 
Patients attending a Primary Health Care Clinic at Rethabile Health Centre in 
Polokwane were invited to participate in this study by the researcher using various methods. 
Posters and notices with information about the study were placed on notice boards at strategic 
points in the facility e.g. patient waiting rooms, to invite participants. The notices and posters 
were written in English and were translated into Northern Sotho (a common language in the 
study area) in order for the posters to be linguistically accessible to a broad range of people 
(See Appendix A, Appendix B and Appendix C). Clinical staff seeing chronic patients at the 
chronic illnesses section at the facility also assisted in identifying potential participants based 
on eligibility criteria of the study.   
Control Group: 
Volunteers from staff of the primary health care centre and nearby provincial hospital 
as well as members of the general public were invited to participate in the study through an 
advertisement in the staff newsletter and notice boards (See Appendix A, Appendix B and 
Appendix C). Notices of the study (in English and Sesotho) were also placed in the local free 




Participants in the cohort group were patients attending a Primary Health Care clinic in 
Polokwane, Limpopo. The participants for the control group were volunteers working or 
residing in the area around the Primary Health Care clinic in Capricon health district, 
Polokwane. There were 192 participants in this study; 110 in the cohort and 82 in the control 
group. There were 40 (13 for the cohort and 27 for the control) potential participants who were 
excluded due to various reasons e.g. age, prior exposure to occupational noise and history of 
head injuries. For some of the audiolgical assessment reporting, individual ears were used as 
sample size and this was done to ensure accurate reporting as some findings were in one and 
not both ears. 
Study context 
The current study was conducted in Polokwane, the provincial capital of Limpopo 
province. This province has the highest poverty in comparison to other South African 
provinces, with 78.9% of the population living below the national poverty line (Statistics South 
Africa, 2013). In terms of language, Sesotho is spoken by most of Limpopo's population. Most 
access health care at public health facilities similar to the data collection site which is located 
centrally in Polokwane, the province’s capital. The data collection site, Rethabile Health Centre 
was ideal for accessing partipants as it is one of the biggest primary health care clinics that 
serves residents of the Capricon health district. Also, the facility was selected as it has a large 
chronic disease clinic managing patients with various diseases with diabetes as one of them. 
Limpopo province accounts for 2.8% of the national prevalence numbers in of people aged 25 
years and older, after Gauteng and North West in ranking (Statistics South Africa, 2011). 
Furthermore, the incidence of diabetes in Limpop province is reported at 2.5 cases per 1000 





Data collection tools: 
a) Data abstraction sheet- The data abstraction sheet was developed by the researcher 
specifically for this study based on information that was needed. Information captured 
in the abstraction sheet included participant age & gender, diabetes characteristics 
(cohort only) and other relevant medical information. (See Appendix D).  
b) Audiological assessment tools- See Appendix E with all the audiological tests 
administered. Audiological testing was administered in a soundproof booth with the 
following equipment:  
a. Welch Allyn Otoscope: to examine the ear canal and the tympanic membrane  
b. GSI 61 clinical audiometer: used to determine participants’ pure tone hearing 
thresholds with pure tone audiometry assessments.  
c. GSI Audera version 2.7: used to administer diagnostic otoacoustic emissions 
assessments. 
c) Charted audiogram- Audiological information of the patients was recorded onto a 
charted audiogram (See Appendix F).  
d) Balance assessment tools- Balance function information was obtained from two main 
assessments, the Modified Clinical Test of Sensory Integration of Balance (MCTSIB) 
and the Dynamic Gait Index (DGI) (Shumway-Cook & Horak, 1986; Shumway-Cook 
& Woollacott, 1995). Tools for the MCTSIB were as follows; a Temper® foam (also 
called T-foam 4 inches thick, medium density T41 firmness rating) and a stopwatch. 
Tools for the DGI were as follows; a shoe box, measuring tape, gait belt, cones (traffic 
safety cones) and a 6 meter distance measured on the floor with tape.  
e) Balance assessment score sheets- Scoring for both balance tests was recorded on the 
respective scoring sheets. (See Appendix G and Appendix H).  
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f) Diabetic neuropathy symptoms score (DNS)- Screening for peripheral neuropathy
specifically of the lower limbs was carried out using this tool (Meijer et al., 2003). (See
Appendix I).
g) Visual screening chart- Screening for visual acuity was carried out using this tool
(Pandit, 1994). (See Appendix J).
Data Collection Procedure 
1. Ethics approval was first sought and obtained from the Faculty of Health Sciences
Human Research Ethics Committee, University of Cape Town (HREC/Ref:134/2015)
(See Appendix K).
2. Thereafter permission to conduct the study was sought and obtained from the Limpopo
Department of Health (See Appendix L and Appendix M).
3. Recruitment of participants followed after ethical clearance and permission from
relevant authorities was granted. Recruitment of participants was done mainly via
notices that were placed at the clinic notice boards. Patients in the waiting room were
also approached in person, informed about the study and given the written study
information and then invited to participate in this study. (See Appendix A and Appendix
B).
4. Pilot study: a pilot trial was conducted on the first 10 participants with the aim of
clarifying the study process, resource needs and data management for the main study
(Kar & Ramalingam, 2013). The outcome of the pilot study did not indicate a need to
modify data collection protocol for the main study.  Data collected from the participants
in the pilot study were included in the main study data analysis. Data collection for the
main study commenced shortly after the completion of the pilot study.




a.  Given the study information sheet (See Appendix O).  
b. Given consent form to sign as an indication of their willingness to participate in 
this study. (See Appendix P). 
c. Participants were then assigned into the cohort and or cohort group and assigned 
study numbers. 
6. Thereafter participants were taken into the audiology room for the case history 
interview. 
a. Case history interview with participants of both groups included questions to 
ascertain participant medical and social information as needed for the study (See 
Appendix D).  
b. Recording of medical details on data abstraction sheet was done. For 
participants in the cohort group, information on the diabetes characteristics 
(type, duration and glycemic status) was recorded from their medical folders. 
All the diabetes characteristics information was pre-recorded into the medical 
folders by the nurses that conduct the monthly chronic clinic to monitor the 
patients. 
7. After case history, the participants underwent audiological and balance assessments. See 
Appendix E with all the information about data collection tests, test instructions and 
norms thereof. Testing protocol was as follows: 
a. Audiological assessments: 
i. Otoscopy 
ii. Pure Tone  Audiometry. The Modified Hughson-Westlake procedure 
(Carhart & Jerger, 1959) was used to establish the pure tone thresholds. 
The hearing threshold for any given frequency was defined as the lowest 
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intensity level in dB HL where a participant hears a sound 50% of the 
time  (Carhart & Jerger, 1959). 
iii. Diagnostic Otoacoustic emissions 
b. Prior to the balance assessment, visual acuity and lower-limb neuropathy 
screening assessments were carried out. See Appendix I and Appendix J.  
c. Balance assessment proceeded as follows: 
i. Modified Clinical Test Of Sensory Integration 
ii. Dynamic Gait Index  
8. After all testing, the researcher reviewed the results and counselled participants on 
findings. In instances where abnormalities were detected, the researcher made the 
appropriate referrals for the participants at their local/closest healthcare facility. 
Data collection personnel 
Data collection was conducted and managed by the researcher who is a qualified 
audiologist. The researcher administered the audiological and balance assessments for all the 
participants in both groups. The visual acuity and lower-limb neuropathy screening 
assessments were administered by the researcher as they are screening tests. The researcher has 
consulted both the optometrist and internal medicine doctors for training in the short 
assessment methods. All the data collected was collated by the researcher into an Excel sheet.  
Reliability and Validity 
Reliability refers to the consistency of measurements and can be assumed when the 
same result can be obtained should the same methodology be utilized (Odom & Morrow, 2006). 
Validity refers to the extent to which an empirical measure adequately reflects the meaning of 
the concept under investigation (Odom & Morrow, 2006). Validity is achieved when a study 
measures that which it intended to measure. (Odom & Morrow, 2006). In this study there were 
a variety of instruments used to quantify the variables of interest and their validity and 
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reliability is discussed in Table 2. In capturing of all information, intra-rater reliability was 
calculated in 10% of the sample. Intra-rater reliability calculation was carried out by re-entering 
data in and recorded onto a separate spreadsheet to compare. The process of re-entering of data 
was carried out in a blinded manner (no participant names) by using participant’s research 
numbers. A comparison of the two separate records was undertaken with expectation to attain 
> 90% reliability using the following formula: (Agreement)/ (Agreement + Disagreement) x 
100 (de Vet, Terwee, Knol, & Bouter, 2006).  A 94% reliability outcome was attained.  
Table 2  
Reliability and Validity 
Test Reliability & Validity 
Pure tone 
audiometry 
All assessments administered by the researcher in this study were routine clinical tests with established reliability and validity in clinical practice. 
All testing equipment complied with the South African National Standard (10154-1/2 10182) and were calibrated for the years 2014-2015 to 
ensure valid results. The researcher also carried out daily biologic checks of the equipment to ensure consistent function and instrument validity 
before assessing study participants. To ensure reliable auditory thresholds were recorded from participants, researcher retested threshold at 1 kHz 
in the best ear and reliable auditory thresholds were assumed when the retested threshold was within 5-10 dB of the previously obtained threshold. 
If reliable auditory thresholds were not obtained, the participant would be retested in both ears.  
For participants that presented with wax prior pure tone audiometry, wax was removed in order to avoid impact of wax on hearing level findings. 
DPOAE DPOAE assessments have been documented by Hall and Swanepoel (2010) as a sensitive and site specific measure of cochlear function. OAE 
assessments are also considered reliable as they are an objective measure and have minimised subjective feedback with automated computer 
systems (Hall & Swanepoel, 2010). To ensure reliability, the researcher administered OAEs in a quiet sound proof room to avoid interference 
from external noise. OAEs measurements were repeated twice; [first test was done, ear probe was taken out and replaced back in the canal, then 





According to Wrisley and Kumar (2010) the DGI as an assessment tool can predict dynamic balance disorders with a good inter-rater reliability. 
Furthermore, Wrisley and Kumar (2010) reported the DGI as a tool to have adequate discriminative ability with 0.84, Sensitivity and 0.89, 
Specificity to identify dynamic balance and gait impairments as well as quantify fall risk. The MCTSIB according to Yim-Chiplis and Tablot, 
(2000) is a reliable tool to assess balance function in terms of sensory integration and dynamic balance. Cohen et al., (2014) in their study 
established the efficacy of the MCTSIB as a screening assessment for balance function. The researcher administered both the DGI and MCTSIB 
according to the tool instructions to ensure instrument validity. To ensure test-retest reliability, a subset (10%) of participants were tested twice 
and a correlation coefficient (r) > 0.7 was accepted for a good repeatability of the instrument. 
DNS The Diabetic Neuropathy Symptom Score has been evaluated in 73 diabetic studies, it was found to have a reliability of 0.64, a sensitivity of 
79% and a specificity of 78% in screening for the presence of lower limb neuropathy in a diabetic population (Dias, Nienov,  Parisi, & Schmid, 
2015). To ensure appropriate screening was administered with the DNS, the researcher was trained by the internal medicine doctor at the facility 
to carry out the screening assessment.  
Snellen E 
chart 
The Snellen E chart has been used as a vision screener in various studies and was found to be a reliable and most common measure for visual 
acuity screening (Pandit, 1994). The researcher consulted with an optometrist on how to administer the visual screening chart to ensure the 
appropriate protocol is followed for valid results. The Snellen E chart is a good measure for illiterate persons as well, as it can be administered 
similar to the tumbling E chart where the participant only indicates the direction of the ‘E’. 
Ethical considerations 
This study adhered to the ethical principles outlined in the Declaration of Helsinki, (2013) 
throughout its completion to ensure transparency, integrity of data and respect for participant 
dignity as well as their physical well-being (Krleža-Jerić & Lemmens, 2009; World Medical 
Association, 2013). Furthermore the Belmont principles (1979) were used in the study to ensure 
adherence to ethical guidelines regarding human research to ensure respect for persons, 
beneficence and justice (Irving, 2013). 
Autonomy: Informed Consent 
Autonomy of the participants was ensured through informed consent. The participants 
were given adequate information (in the language that they understand through bilingual [English 
& Sotho] oral presentations in the waiting area) to enable them to make an informed decision to 
participate voluntarily in the study. Consent forms for the participants included a separate 
information sheet about the details of the study (See Appendix N) and participants were asked to 
sign the informed consent form prior to commencing with the study to indicate their willingness 
to volunteer to participate in the study which was in line with the Declaration of Helsinki, (2013) 
(See Appendix O and Appendix P) (Irving, 2013; World Medical Association, 2013). For those 
that could not read, the consent and information sheet was read to them by the researcher and they 
made an X to sign the consent slip. Participants were made aware that they have the right to 
withdraw from the study at any time (without negative consequences to them).   
Beneficence 
The principle of beneficence entails that researchers should act in the best interest of the 
participants at all times (Irving, 2013; World Medical Organization, 1996). There were no direct 
benefits for the participants in this study; however when any abnormalities were  detected, 
participants were counselled and referred to the provincial hospital nearby with all necessary 
resources for further management. In the interest of not unduly burdening the audiological services 
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in the Capricon district health, referrals were made to all districts in the province within access 
and choice of the participants to equally disperse potential patient load.  
Nonmaleficence 
 The principle of nonmaleficence (absence of harm to the research participant) in line with 
the Belmont beneficence principle was used in this study mainly to protect patients by minimising 
risks in the study (Irving, 2013; Rhodes, 2010; World Medical Organization, 1996). There were 
no significant direct risks identified for the participants in this study. In terms of assessment for 
balance, risk of falls was mitigated by using a gait belt throughout assessment.  
Justice  
Justice is the act of distributing the burdens or benefits of a society fairly amongst the 
people involved (Irving, 2013; Rhodes, 2010). All the patients that consented to the study and met 
the inclusion criteria were part in the study. The sampling method allowed for all the available 
participants to join fairly and equally in line with the Belmont principle of justice (Irving, 2013; 
Rhodes, 2010). Furthermore, according to distributive justice principles, the possible identified 
risks and gains identified applied equally to participants and the benefits/gains of the study were 
used to enhance service delivery in the same community (Irving, 2013). 
Anonymity 
In order to ensure participant’s information was available only to the researcher and when 
participants signed informed consent to join the study, thereafter all medical information was 
recorded along the participants’ assigned study number. Furthermore, all data collected was kept 
in a excel spreadsheet on the data collection computer that was always password protected and 
only accessible to the researcher. Last, in terms of publication of results, no patient names or 
identifying data will be included, only assessment findings which patients consented to on signed 




In this study, data analysis was done using both descriptive and inferential statistics 
(Coolican, 2004). (See Table 3).  
Table 3 
Methods for descriptive statistical analysis 
Variables Statistical Tests for Analysis 
Hearing Loss: 
 
Prevalence & type  Proportions (%), Frequency tables 
Severity (Using cPTA & HF-PTA 
calculations) 
Tinnitus: Prevalence & type Proportions (%), Frequency tables 
OAE: Normal or not. 
Norms: A DPOAE was regarded as present 
with a signal to noise ratio > 6 dB as well as 
absolute DPOAE level > 0 dB (Botelho et 
al., 2014). 
Proportions (%), Frequency tables 
Balance: DGI Proportions (%), Frequency tables 
MCTSIB 
Diabetes: Type, Duration, Control Proportions (%), Frequency table 
Median, Range 
Mean, Standard Deviation 
Patient Factors: Age, Gender Proportions (%), Frequency tables 
Co-
morbidities: 






 The Pearson’s correlation coefficient was used to determine the strength of associations 
between the presence of hearing loss, tinnitus and balance dysfunction with characteristics 
of diabetes (type, control and duration), patient specific factors (age, gender) and presence 
of comorbidities (hypertension, etc). Pearson’s correlation coefficient were interpreted as 
follows:  
o A value of 1 indicated a total positive linear correlation, 0 showed no linear 
correlation, and −1 indicated a negative linear correlation. 
 The logistic regression model was used to determine odds ratios. Odds ratios obtained 
showed the relative risks of hearing loss, tinnitus and balance disorders with diabetic 
patients. Interpretation of odds ratio findings were as follows: 
o An odds ratio of exactly 1 indicated that exposure to diabetes does not affect the 
odds of hearing loss, for example.  
o An odds ratio of more than 1 means that there is a higher odds of hearing loss 
happening with exposure to diabetes. 
o An odds ratio is less than 1 is associated with lower odds. 
 Independent T-tests were also used to determine significance of differences in prevalences 
between the cohort and control group data. In this study, the significance level (alpha) was 
taken at 0.05 (Coolican, 2004). 
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Chapter 4: Results 
Introduction: This chapter will present the findings according to the study objectives. The 
chapter starts with presentation of demographic data; sample size, gender and age distribution as 
well as diabetes and other comorbidities (cohort group only). Thereafter, the results regarding 
auditory and balance characteristics of the participants will be presented  
Participant description 
A total of 232 individuals consented to participate in this study; 123 in the cohort and 109 
in the control group. A total of 40 of the potential participants; 13 in the cohort group and 27 in 
the control group, could not be included in this study because they did not meet the inclusion 
criteria for the study. Most of the exclusions were either due age or prior exposure to occupational 
noise. The resultant study sample was a total of 192 participants; 110 in the cohort and 82 in the 
control arms of the study respectively. There were similar proportions of  males and females in 
each arm of the study and majority of the participants were ≤ 49 years old with a range of 20 to 
55 years; (cohort; M =46, SD =8.24, control; M =43, SD =9.94). (see Table 4). The difference in 
distribution of the ages between the cohort and control groups was not statistically significant 
across all age bands. 
Table 4 
Participant demographics. 
Description Control (n =110) [n, (%)] Cohort (n = 82) [n(%)] Statistical Significance (α = 0.05) 
Gender (%) 
Males 53(48%) 41(50%) 
t(175) = -0.58, p = .56 
Females 57(52%) 41(50%) 
Age (years) 
20-30 years  13(12%) 4(5%) t(6) = -0.75, p = .48 
31-40 years 25(23%) 13(16%) t(34) = 1.51, p = .14 
41-49 years 27(24%) 25(30%) t(37) = -0.80, p = .42 
>49 years 45(41%) 40(49%) t(60) = 1.37, p = .17 
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Cohort description: Diabetes & Comorbidities  
The cohort group was the group of participants with the main variable of interest for the 
study, diabetes. Majority (92%) of the participants presented with type II diabetes and most had 
an uncontrolled glycemic status (see Figure 1 and 2). The duration of disease ranged from a month 
post diagnosis to 33 years and most were living with diabetes for less than 5 years. 
 
In terms of co-morbidities, more than half of the participants in the cohort group had a 
comorbidity with their diabetes (see Table 5). The comorbidity with the highest prevalence was 
hypertension.  
Table 5  
Co-morbidities. 
Comorbidity Number of participants (n) Percentage (%) 
Hypertension 62 56% 
Positive for Diabetic Neuropathy  56 51% 
Failed the vision screener 62 56% 
*Co-morbidities only investigated in the cohort (diabetic) group. 
  
Figure 1: Diabetes Type Distribution. Figure 2: Diabetes Control: Glycemic Status 
8%
92%






Auditory Status:  
The hearing status findings were recorded per ear to enable accurate recording of 
asymmetrical unilateral findings. Most participants had symmetrical hearing in both groups, 
regardless of hearing loss presence, cohort (80%) and control (71%) . 
Hearing loss: prevalence 
The prevalence of hearing loss was higher in the cohort than the control group with both 
cPTA and HF-PTA (see Table 6). The difference in the hearing loss prevalence between the groups 
was found to be statistically significant with both cPTA, t(376) = -3.06, p = .002 and HF-PTA 
t(377) = -7.47, p < .001.  
Table 6  
Prevalence of hearing loss. 
 For the purposes of describing more information on hearing loss findings, the HF-PTA 
will be used to define hearing loss presence in the remainder of this report. 
  
Description Cohort (n) Control (n) 
Total sample size 110 82 
Total number of ears in sample  220 164 
Number of ears with normal hearing  [n(%)] [n(%)] 
cPTA  (Conventional) 138(63%) 124(76%) 
HF-PTA (high frequency) 98(45%) 132(80%) 
Number of ears with hearing loss [n(%)] [n(%)] 
cPTA (Conventional) 82(37%) 40(24%) 
HF-PTA (high frequency) 122(55%) 32(20%) 
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In terms of co-morbidities and hearing loss, it was found that in those with diabetes and 
hypertension, there was more than double the amount of ears with sensorineural hearing loss when 
compared to those without hypertension (54% and 25% respectively). In those with diabetes and 
possible diabetic peripheral neuropathy, there were more ears with sensorineural hearing loss 
compared to those without neuropathy (see figure 3). 
 
Figure 3: Hearing loss and comorbidities. 
 A logistic regression analysis was done to investigate the odds of hearing loss presence 
with the following (independent) variables; gender, age, diabetes characteristics (duration and 
control) and the presence of hypertension (see Table 7, next page).  
The outcome of the regression analysis indicated that an increase in diabetes duration was 
associated with an increase in the odds of hearing loss presence (OR=1.12, 95% CI: 1.02 -1.23, p 
=0.01). A similar pattern was observed in the case of age where an increase by a year also showed 
higher odds of hearing loss presence (OR=2.9, 95%CI: 1.19-7.07, p =0.01). Furthermore, with 
gender, in comparison to female participants, males had significantly higher odds of hearing loss 

























Number of ears with SNHL
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Table 7  
Logistic Regression Model Results. 
Predictor Variables Odds Ratio 
P Value 
(α= 0.05)   
95% Confidence Interval 
Lower Upper 
Diabetes duration (years) 1.120859 0.013 1.024482 1.226303 
Diabetes control (g.mol) .9920032 0.786 .9362205 1.05111 
Age (years) 2.904431 0.019 1.191974 7.0771 
Gender¥  .2661657 0.005 .1045702 .6774794 
Presence of hypertension 1.847933 0.215 .7005446 4.874572 
* Regression calculated with n = 110, R2 = .181 and Log likelihood = -62.149578.  ¥ reference variable = female  
Hearing loss: Type & Severity 
Sensorineural hearing loss was the most prevalent type of hearing loss observed in both 
groups (see Table 8, next page). Sensorineural hearing loss was present in a higher proportion of 
ears in the cohort than the control. Majority of the hearing losses observed in both groups) were 
of a slight degree (16-25 dB HL).  There were relatively more ears (up to 3 times more) with 
disabling hearing loss (> 41 dB HL) in the cohort (48) than the control (10) group.  
Otoacoustic Emissions: 
In addition to pure tone audiometry, diagnostic distortion product otoacoustic emissions 
(DPOAE) were administered and recorded per ear and categorised into low (< 2.5 kHz) and high 
(>2.5 kHz) frequencies. DPOAE findings were consistent with pure tone audiometry results in 
that there was a higher proportion of ears with abnormal findings in the cohort than control group. 
(see Table 9, next page). The difference in DPOAE findings between the participant groups were 
found to be statistically significant in the higher frequencies with both signal to noise ratio (t(381) 




Type and severity of hearing loss 
*Hearing loss severity classification according to Harrell (2002).
Table 9 
Abnormal diagnostic DPOAE Findings 
Low Frequencies High Frequencies 
Signal to Noise Ratio (dB) (n [%]) 
Cohort (n=220) 112(51%) 186(85%) 
Control (n=164) 39(24%) 107(65%) 
Significance of differences t(290) = -1.24, p = .21 t(381) = -6.65,p < 0.01 
DPOAE level (dB SPL) (n [%]) 
Cohort (n=220) 89(40%) 213(97%) 
Control (n=164) 65(40%) 139(85%) 
Significance of differences t(358) = -8.06, p < 0.01 t(323) = -3.99, p < 0.01 
*n= number of ears. Norms used for DPOAE: signal to noise ratio > 6 dB, DPOAE level > 0 dB (Botelho et al., 2014).
Description 
Cohort  
number of ears (%) 
Control  
number of ears (%) 
Number of ears with hearing loss 122 32 
Total number of ears in sample  220 164 
Type of Hearing loss 
Conductive 7(6%) 4(12%) 
Sensorineural 91(74%) 22(67%) 
Mixed 24(20%) 7(21%) 
Severity of Hearing loss 
Slight       (16-25 dB HL) 42(35%) 14(44%) 
Mild         (26-40 dB HL) 32(26%) 8(25%) 
Moderate (41-70 dB HL) 39(32%) 7(22%) 
Severe     (71-90 dB HL) 9(7%) 3(9%) 




The presence or absence of tinnitus was based on participants’ subjective reports during 
case history interview. A higher tinnitus prevalence was found in the cohort (44%) compared to 
the control group (15%).  
The difference in  tinnitus prevalence between the groups was found to be statistically 
significant (t(190) = -4.41, p < .001). Specific to the cohort group, the correlation between tinnitus 
reports and diabetes duration (years post diagnosis) and control (glycemic status) was investigated 
using the pearson correlation coefficient. A weak inverse relationship (r= - .02) was found 
between diabetes duration and tinnitus presence and no relationship (r= .00) was found between 
diabetes control and the presence of tinnitus.  
Balance Functions:  
DGI findings: 
The DGI consisted of 8 tasks with varying demands, with each item was scored on a 4-
level ordinal scale with a maximum possible scoreof 24. A score of 19 or less indicated an 
increased risk of falling ( Leddy et al., 2011; Wrisley et al., 2003). Findings show that twenty-two 
percent of participants in the cohort group failed dynamic balance screening assessment (i.e. DGI 
scores < 19) and therefore were at risk of falls when compared to one percent in the control group. 
The difference in the number of participants that failed the dynamic balance screening with the 
DGI between the groups was statistically significant (t(166) = -6.14, p < .001). The distribution of 
the DGI scores of the cohort and control is illustrated in Figure 4.  
The correlation between DGI scores and participants’ age was also analysed using the 
Pearson correlation coefficient. The results indicated weak inverse correlations between DGI 
scores and age with r= - .29 and r= - .37, for the cohort and control groups respectively. Specific 
to the cohort group, the correlation of DGI score with diabetes duration (years post diagnosis) and 
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control (glycemic status) was also investigated using the Pearson correlation coefficient. The 
findings also showed a weak inverse correlations with diabetes duration r= - .13 and diabetes 
control r= - .23, indicating that a longer diabetes duration in years and a higher glycemic status 








The MCTSIB was carried out over four conditions which are eyes open and closed with 
foam and firm surface. Participants were timed in each condition with the standard at 30 seconds 
and the total score was out of 120 seconds (Leddy et al., 2011). MCTSIB scores show that more 
than half (56%) of the participants in the cohort group failed the static balance screen (scores <120 
seconds) when compared to 21% of the control participants. The difference in the number of 
participants that failed the static balance screening between both participant groups was 




















Figure 4. DGI score distribution. *maximum scores at 24 


























The distribution of the MCTSIB scores, as indicated in Figure 5 show that the cohort and 
control groups had minimum scores of 60 and 90 seconds, respectively. Participants with abnormal 
findings (<120s) in both groups, mostly had difficulties in condition three and four (see Figure 6). 
Analysis of correlation between MCTSIB scores and participant age using the Pearson 
correlation coefficient also yielded weak inverse correlations with r= - 0.29 and r= - 0.14 for 
cohort and control groups respectively thus indicating that increasing age was weakly related to a 
lower MCTSIB score. Specific to the cohort group, the correlation between MCTSIB score and 
diabetes duration (years post diagnosis) and control (glycemic status) was also investigated. 
Pearson correlation coefficient findings showed a weak negative correlation with diabetes duration 
r= - 0.20 and diabetes control r= - 0.06, indicating that with longer diabetes duration in years and 
a higher glycemic status, a lower MCTSIB score was obtained.  
Diabetes comorbidities and Balance findings: 
Further analysis was conducted to determine the likelihood of abnormal balance screening 
test findings in patients with diabetes and were positive for those with diabetic neuropathy and 





























Figure 6. MCTSIB conditions. 
*Conditions: 1= on firm surface, eyes open, 2= on firm surface, eyes closed, 3= on foam surface, eyes open, 4= on foam surface, eyes closed
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and one or both comorbidities, consistently presented with a higher prevalence of abnormalities 
compared to those without comorbidities (see Table 10).  
Table 10 
Diabetes comorbidities and Balance findings 
Participants with diabetes Number of 
participants 
Abnormal 
DGI [n (%)] 
Abnormal 
MCTSIB [n (%)] 
Participants positive for diabetic neuropathy 56 22(39%) 40(71%) 
Participants negative for diabetic neuropathy 54 3(6%) 21(39%) 
Participants that failed vision screening 62 15 (24%) 50(81%) 
Participants that passed vision screening 48 9(19%) 25(52%) 
Participants positive for diabetic neuropathy 
and failed the vision screener 
31 11(35%) 27(87%) 
Results summary: 
Overall, participants with diabetes presented with a statistically significant higher 
prevalence of abnormalities for both auditory characteristics and balance function than those 
without diabetes. A higher prevalence of hearing loss and abnormal cochlear function was found 
in those with comorbidities (hypertension and neuropathy) and the likelihood of hearing loss 
presence was associated with diabetes duration and participant factors (age & gender). A similar 
pattern was found with balance function where a higher prevalence of abnormalities was found 
with those with comorbidities (possible neuropathy and visual difficulties) and uncontrolled 





Chapter 5: Discussion and Conclusion  
Introduction: This chapter will discuss the study findings in relation to existing literature. 
In addition, the chapter will present the researcher’s commentary on the findings and their relation 
to clinical practice. Strengths and weaknesses of the current study will also be discussed and 
finally, clinical implications, recommendations for future research and conclusions based on the 
study findings will be presented. 
The current study sought to describe the auditory characteristics and balance function in a 
group of South African patients with diabetes (cohort group) and compare that to a group of 
volunteer participants without diabetes (control group). Overall findings of this study showed a 
higher proportion of auditory abnormalities and balance dysfunctions in participants with diabetes 
than the control group.  
The prevalence of hearing loss amongst patients diagnosed with diabetes in this study was 
found to be 55%. This is a slightly higher prevalence finding than previous study reports of 13.1% 
(Kakarlapudi et al., 2003), 43.6% (Pemmaiah & Srinivas, 2011) and 45% (Mozaffari et al., 2010). 
Several factors may be plausible explanations for the variation in prevalence percentages of 
hearing loss reported in different studies, such as the use of different classifications of hearing loss 
in terms of the normative cut-off (in dB HL); and PTA calculations.  
To classify hearing loss, a low cut off hearing level norm (15 dB HL) was used in this 
study to acknowledge a slight hearing loss (16-25 dB HL), which is not typically acknowledged 
by many researchers in their findings (Timmer, 2014; Kaderavek & Pakulski, 2002) even though 
it is known to impact speech discrimination and comprehension even in adults (Arlinger, 2003). 
Also, the current study made use of a HF-PTA in line with literature evidence indicating that 
diabetes related hearing loss mainly affects the high frequency hearing thresholds (2-8 kHz) which 
may be missed by the conventional PTA calculation (0.5-2 kHz) (Pemmaiah & Srinivas, 2011; 
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Mozaffari et al,2010). With the use of a HF-PTA and a low cut-off norm to classify presence of 
hearing loss in the current study, there was an additional 42 ears (35%) with slight high frequency 
hearing loss identified, which may have otherwise been missed. It can be argued that identifying 
more individuals with slight hearing loss, can increase the caseload of individuals with hearing 
loss, which may potentially create an additional burden to the health care system. However, in a 
resource constrained environment such as South Africa, early identification of hearing loss (no 
matter how slight), in a population at risk for hearing loss such as patients with diabetes can prompt 
early patient education on how to cope with hearing loss (Arlinger, 2003).  
In terms of type of hearing loss, most studies investigating hearing loss in patients with 
diabetes did not report on all types of hearing loss (Botelho et al., 2014; Panchu, 2008; Pemmaiah 
& Srinivas, 2011; Mozaffari et al., 2010). Although sensorineural hearing loss may be the most 
prevalent type of hearing loss in patients with diabetes, other hearing loss types are are worth 
noting and discussing. In this study, conductive and mixed hearing losses, were found in 15% and 
26% respectively among patients with diabetes. Similar findings were reported by Thimmasettaiah 
and Shankar (2012) with mixed hearing loss in 16% of their participants with diabetes. Hearing 
losses attributed to outer and middle ear pathologies such as otitis externa and otitis media should 
not be overlooked in patients with diabetes because their ability to heal and recover from wounds 
and infections may be compromised. Furthermore, unlike sensorineural hearing loss, losses 
attributed to outer and middle ear pathologies can be treated and reversed if detected early.  
With respect to severity of hearing loss, moderate or worse hearing loss (i.e. thresholds > 
40 dB HL) was established in a higher proportion in the cohort group (82%) than the control 
(18%). Moderate or worse hearing loss can be disabling as it can negatively impact audibility, 
discrimination and comprehension of sound and speech to the listener (Timmer, 2014) and often 
requires intervention in the form hearing amplification. Reports of a high proportion of ears 
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diagnosed with disabling hearing loss in patients with diabetes is not unique to this study, previous 
studies like that of Pemmaiah and Srinivas (2011) also reported more than 20% of their 
participants had moderate to severe hearing loss. However, despite this strong evidence of a high 
proportion of disabling hearing loss in patients with diabetes reported in literature, it is a concern 
that disabling hearing loss is still not recognized as a comorbidity of diabetes.  
The presence and severity of hearing loss in patients with diabetes in previous studies has 
been associated with diabetes characteristics such as type, control and duration (Mitchell et al., 
2009; Sunkum & Pingile, 2013). However, the current study did not find any such association. 
The difference in findings between the current study and previous studies may be due to 
differences in the participants’ characteristics of the diabetic group and or study design. For 
instance, Mitchell et al. (2009) study involved a much larger sample size (n=3654) than the current 
study (n=192) and their study used a longitudinal design compared to a cross-sectional design in 
the current study. Also, Sunkum and Pingile (2013) recorded control of diabetes from fasting 
blood glucose measurements unlike the current study that used glycohemoglobin blood test results 
which are the ideal measurement to monitor diabetes control over a 3 month period in patients 
(American Diabetes Association, 2012). 
Diabetes related hearing loss has also been associated with diabetes duration (Frisina et al. 
2006). The current study also found that each year increase in diabetes duration was associated 
with about 12% (OR: 1.12) increase in odds of hearing loss. Similar findings were also reported 
by Mitchell et al. (2009) and Akinpelu et al. (2014) who reported that a longer duration of 
hyperglycaemia was associated with a higher risk of pathological outcomes in the inner ear. These 
findings are in line with the hypothesis that an increased diabetes duration implies increased 
patient age, which is, apart from diabetes presence, a risk factor for hearing loss (Frisina et al., 
2006). Moreover, the current study also found that an increase by one year in participant’s age 
57 
 
was associated with increased odds of hearing loss presence (OR: 2.9, p = 0.01). In agreement, 
Frisina et al. (2006) and Kakarlapudi et al. (2003) found that diabetic changes appear to accelerate 
or act in synergy with age related deterioration in the ear. The current study findings also 
highlighted that, in adults younger than 49 years, age was a predictor variable for hearing loss 
although this age group may not be identified to be at risk for age related impact to their hearing 
(Blevins, 2015). This is important to note as it indicates that even in a younger population, diabetes 
may contribute to hearing deterioration (Sparring et al., 2013).  
In terms of comorbidities, previous studies have associated hearing loss in patients with 
diabetes with hypertension (Bainbridge, Yiling & Cowie, 2010; Bos & Agyemang, 2013). Among 
participants with diabetes, the current study found that in comparison to participants without 
hypertension, those with hypertension had a 84% higher risk of hearing loss. Similar findings were 
also reported by Li, Gong, Yang and Yu (2003) who stated that hypertension is a key risk factor 
associated with deterioration of the cochlea. Furthermore, it has long been established that 
hypertension and diabetes work synergistically against hearing acuity, even in age controlled 
studies (Duck, Prazma, Bennett, & Pillsbury1995). Physiologically, the combination of 
hypertension and diabetes is thought to have a multisystem vascular and end-organ damage in the 
cochlea that in turn is associated with high-frequency sensorineural hearing loss (Duck et al., 
1995). Whilst, the current study did not aim to attribute the cause of hearing loss in those with 
both diabetes and hypertension, findings showed 54% of those with hypertension had 
sensorineural hearing loss compared to 25% in those without hypertension. These findings are in 
agreement with Duck et al. (1995) in their association of hypertension and hearing loss. This is 
important to note as findings can be used to identify those with both diabetes and hypertension as 
an at risk population should universal hearing screening in all patients with diabetes not be feasible 
in a resource constraint context like South Africa. 
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This study also found a significantly higher prevalence of tinnitus in patients with diabetes 
(43%) when compared to the control group (15%) (p < .001). Gribin, Melo and Marchiori (2013) 
in their study (n=498) also reported a high prevalence of tinnitus (42%) amongst patients with 
diabetes and further associated tinnitus with diabetes and hypertension. Tinnitus has been reported 
as a pre-clinical indicator of hearing loss as well as a co-morbidity in those with hearing loss, 
diabetes, hypertension and other age related disorders (Gribin et al., 2013). Physiologically, the 
correlation between tinnitus and diabetes is understood to result from inner ear modifications 
caused by hyper-viscosity or micro-angiopathy resulting from diabetes or hypertension (Gribin et 
al., 2013). Clinically significant tinnitus is important to detect and manage as it has been proven 
as a significant negative impact to mental and emotional wellness of those affected (Rent, 
Bhojwani, Bhat & Unnikrishnan, 2013). However, it is important to note that the current study did 
not investigate whether the participants were bothered by their tinnitus or not, to make it a 
clinically relevant symptom.  
With respect to participant characteristics, males with diabetes had significantly higher 
odds of hearing loss presence (OR: 0.74, p < 0.01), in comparison to females with diabetes. Several 
studies have reported that hearing loss is generally more common in men than women 
(Sharashenidze, Schacht & Kevanishvili, 2007). The difference in risk to acquire hearing loss 
between men and women has been attributed to occupational differences, reaction time to 
symptoms and or frequency of doctor’s visits (Sharashenidze et al., 2007). Also, women have been 
shown to take better care in issues of health than men (Sharashenidze et al., 2007). Therefore, 
findings in the current study on gender as a predictor variable for hearing loss are in line with 
literature independent of the presence of diabetes. These findings can be utilized to emphasise 




Diabetes and balance    
Twenty-two percent (22%) of the participants with diabetes in this study were at risk for 
falling based on their DGI score when compared to only 1% in the control group. Low DGI scores 
are indicative of increased fall risk in participants with diabetes. Similar findings were reported 
by Juregui-Renaud et al. (2009) who also found that 38% of their participants with diabetes 
experienced instability when walking. Other authors explain that fall risk in patients with diabetes 
may be due to decreased sensorimotor function, musculoskeletal deficits, foot and body pain as 
well as pharmacological complications and peripheral neuropathy (Salsabili et al., 2011; Ahn & 
Song, 2012; D'Silva et al., 2016; Sturnieks et al., 2008; Walley et al., 2014). In agreement the 
current study also established that in participants with diabetes that screened positive for diabetic 
peripheral neuropathy (n=56), there was more than six times higher prevalence of fall risk at 39% 
compared to those that screened negative (n=54) at 6%.  
Risk of falls in patients with diabetes, especially those with comorbidities like peripheral 
neuropathy, is essential to note. Falls are ranked among the 20 most expensive conditions to treat 
considering hospitalization, possible need for surgery and thereafter implications for rehabilitation 
(Carroll, Slattum & Cox, 2005). Moreover, in a low socioeconomic context such as the data 
collection site of this study, prevention of falls through health education and balance screening in 
patients with diabetes, may be a feasible strategy to minimise furher strain onto the healthcare 
system.  
It was also found in this study that more than half (56%) of the participants with diabetes 
could not maintain postural stability especially in condition four (eyes closed on foam) of the static 
balance screening with the MCTSIB. According to Rubenstein (2006) postural instability is 
expected in patients with diabetes because most of the affected areas of the body including the 
eyes, ears and the legs, are integral in maintaining proprioception and avoiding falls. In agreement 
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the current study found that in participants with diabetes that screened positive for diabetic 
neuropathy and failed the vision screener (n=31), 87% could not maintain postural stability. 
Postural instability in patients with diabetes with sensory impairments like peripheral neuropathy 
is attributed to the lack of precise proprioceptive response (sensory ataxia) from the lower limbs 
(Walley et al., 2014). Furthermore, Wilson, Garner and Loprinzi (2016) in their study (n=1662) 
reported that visual impairment can impact the vestibulo-ocular reflex, an important system that 
maintains balance and prevents falls. Consequently, there is a crucial need to investigate postural 
instability in order to prevent fall-related injuries especially in patients with diabetes and multiple 
sensory impairments (Wilson et al., 2016).   
Balance dysfunction findings in the current study, along with possible vision loss and 
lower limb neuropathy are imperative to note in relation to the age group affected in the study. 
Majority of participants in this study were middle aged (range: 20-55years), potentially 
economically active adults, thus highlighting that a younger population may be at risk for balance 
dysfunction with multiple sensory impairments including, vision and hearing (Lin et al., 2004). 
Multiple sensory impairments especially in an economically active age range can result in 
significant negative impact to occupational productivity as well as cognitive and functional decline 
(Lin et al., 2004; Wilson et al., 2016). Therefore, the current study findings highlight the need to 
screen for balance function in patients with diabetes at a primary level of care to enable early 
identification and appropriate management to prevent possible impact to quality of life such as 
activity restrictions, decreased social participation and increased need for a doctor’s visit (Agrawal 
et al., 2013). The findings of this study also highlight the need for a multidisciplinary team 
approach inclusive of medical doctors, physiotherapists, optometrists, dieticians and all other 
relevant health professionals in order to provide holistic management of patients with diabetes 
(Van Leeuwen & Bruintjes, 2014).  
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Strengths and Limitations of the Study  
This study comprehensively investigated both the auditory characteristics and balance 
function in patients with diabetes. Previous studies focused on either auditory or balance function, 
seldom was the complete audiological spectrum investigated. Also, the current study design which 
included a matched control group ensured that the influence of confounding variables was 
minimized.  This is in contrast to most of the previous studies that employed mostly retrospective 
reviews of records without control groups. Moreover, the current study used a test battery 
approach in the assessments of participants’ auditory status, including both audiometry and 
DPOAE assessments allowing for cross checking of findings. Lastly, participants were carefully 
selected to ensure that only individuals <55 years old were selected to minimize the impact of age-
related hearing loss and balance dysfunctions which could be confounding variables in this study.   
The current study also had some limitations: first, it was a descriptive cross-sectional study 
with observation/assessments carried out at one time point thus only associations and correlations 
can be inferred. Participants were sampled using non-probability sampling which can introduce 
researcher and selection bias because it is not randomized. Also, there was an unequal number of 
participants between the cohort (n=110) and control (82) groups therefore findings between 
sample groups to be compared with caution. Last, this study investigated mainly prevalence and 
did not include a quality of life aspect that may have added more context with respect to the impact 
of diabetes related hearing loss and balance abnormalities. However, despite these limitations, the 
findings of the current study provide a comprehensive description of auditory and balance 




Clinical Implications  
The clinical implication emerging from the current study is that, in patients with diabetes, 
hearing and balance dysfunctions should be addressed. The findings of the current study also 
indicated that healthcare providers should include, as part of their management, a referral for 
hearing and balance screening for early detection of hearing loss and balance dysfunction. 
Therefore, the current study highlighted the need for an audiologist within the multidiscipliary 
team involved in diabetes patient care. Audiologists need to be more involved in diabetes 
education in health screening and awareness campaigns, especially in the younger economically 
active adults that may also be at risk. Furthermore, audiologists need to start administering hearing, 
tinnitus and balance screening in patients with diabetes, if not universally, should be mandatory 
for those identified to be at a higher risk like, males and those with hypertension.  
 Specific to audiological testing protocols, clinical implications of the current study include 
the use of the high frequency pure tone calculation (PTA: 2, 4 & 8 kHz), more stringent hearing 
loss classification norms (>15 dB HL), inclusion of DPOAE assessments in combination with pure 
tone audiometry, tinnitus screening questionnaires as well as balance screening with readily 
available resources for low-resourced primary levels of care. 
Overall, the findings of the current study suggest that auditory and balance dysfunction 
should be recognized as a comorbidity of/with diabetes. Recognition in instruments such as the 
annual diabetes fact sheets of key organizations like the IDF and WHO will increase awareness of 
the prevalence of auditory and balance dysfunction in patients with diabetes. Also, other official 
documents such as the WHO guidelines for primary healthcare in low-resource settings should 
advocate for diabetes patient education inclusive of hearing and balance matters. At present both 
the WHO and IDF fact sheets have information on diabetes related comorbidities which focuses 
primarily on neuropathies specific to vision and limbs and not on other sensory impairments. This 
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is despite numerous studies documenting the relationship between diabetes, auditory and balance 
dysfunctions(Kakarlapudi et al., 2003). These organizations (IDF, WHO) are significant in 
diabetes education, research and information dissemination thus their recognition will catalyse 
promoting hearing health care amongst patients with diabetes.  
Recommendations for Future Research 
Future research can add to the knowledge base with studies focusing on the following: 
 Incidence of hearing loss and balance dysfunctions in patients with diabetes through 
longitudinal prospective research.  
 Effective methods of hearing and balance dysfunction prevention, management approaches 
and monitoring methods in patients with diabetes.  
 Investigations on the impact of diabetes related hearing loss and balance abnormalities on 
quality of life. 
 Collaborative research with multiple disciplines such as dieticians/nutritionists, occupational 
therapists or physiotherapists, focusing on prevention and management of diabetes related 





In conclusion, the current study has provided a broad description of auditory characteristics 
and balance function in patients with diabetes in a South African population. Overall, the findings 
of this study showed that participants diagnosed with diabetes had a higher proportion of auditory 
and balance abnormalities when compared to those in the control group. With hearing loss, a 
higher prevalence was established in those with comorbidities (hypertension and neuropathy) and 
the likelihood of hearing loss presence was associated with diabetes duration and participant 
factors (age & gender). A similar pattern was established with balance function where a higher 
prevalence of abnormalities was found with those with comorbidities (neuropathy and possible 
visual difficulties) and there was a correlation between uncontrolled diabetes, longer diabetes 
duration and participant age with abnormal balance findings.  
The findings of this study therefore suggest that auditory and balance dysfunctions should 
be considered as comorbidities associated with diabetes. The findings of this study also indicate 
the audiologist’s role for screening, early identification and management of auditory and balance 
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Appendix A: Advertisement for recruitment of control group participants (English) 
WOULD YOU LIKE A FREE HEARING AND BALANCE ASSESSMENT? 
ARE YOU INTERESTED IN PARTICIPATING IN A RESEARCH? 
My name is Vera-Genevey Hlayisi and I am a student from the University of Cape Town. I am 
doing a study to know about diabetes, hearing loss and balance. 
I would like to invite you to be part of this study as part of the group of people that do not have 
Diabetes. This clinical study protocol has been granted ethical approval by the University of Cape 
Town, Human Research Ethics Committee (HREC)  
In summary, if you agree take part in the study, please be aware of the following: 
You will also be asked to give permission to have audiological and balance assessments done. The 
assessments will take 40 minutes to an hour.You will also be asked to give permission to have 
your information be used for research purposes.There will be no costs to you related to 
participating in this research study. You will not be paid or compensated for taking part in this 
study. All information collected about you during the course of this study will be kept without any 
identifiers.  
Taking part in this study is voluntary. If you are interested, come to XXXXX clinic and get more 
information on how to be involved or contact; 
Vera-Genevey Hlayisi (Researcher) 0718376207 blyver002@uct.ac.za 
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Appendix B: Advert for recruitment of cohort group participants (English) 
WOULD YOU LIKE A FREE HEARING AND BALANCE ASSESSMENT? 
ARE YOU INTERESTED IN PARTICIPATING IN A RESEARCH? 
My name is Vera-Genevey Hlayisi and I am a student from the University of Cape Town. I am 
doing a study to know about diabetes, hearing loss and balance. I would like to invite you to be 
part of this study. 
This clinical study protocol has been granted ethical approval by the University of Cape Town, 
Human Research Ethics Committee (HREC). In summary, if you agree take part in the study, 
please be aware of the following: 
You will also be asked to give permission to have audiological and balance assessments done. The 
assessments will take 40 minutes to an hour. You will also be asked to give permission to have 
your information be used for research purposes. Your hospital file will also be used to obtain more 
information about your medical history pertaining diabetes. 
There will be no costs to you related to participating in this research study. You will not be paid 
or compensated for taking part in this study. All information collected about you during the course 
of this study will be kept without any identifiers.  
Taking part in this study is voluntary. If you are interested, come to XXXXX clinic and get more 
information on how to be involved or contact; 
Vera-Genevey Hlayisi (Researcher) 0718376207 blyver002@uct.ac.za 
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Appendix C: Advert for recruitment of both cohort & control group participants (Sotho) 
Naa O nyaka go hlahlofiwa mahala? 
Leina laka ke Vera-Genevey Hlayisi, ke moithuti wa Univesiti ya Cape Town. Ke e thuta go tseba 
ka bolwetshi ba swekere, bothatha ba go otlwa le balance. Ke rata gole mema. 
Research ena e na e humane tumelelo ho Human Research Ethics Committee ya Univesiti ya Cape 
Town. Ge o tseya karolo ya thoto ye o swanetse go dira tse latelago; 
Re tho hlahlofa ditsebe le balance ya hago. Hlahlofo e tlo go tsea metsotso e masometharo go fihla 
go ye masometshela 
Retlo kgopela go bona file ya gago 
Ga yona le patella ke mahala. Le mohlahlubi ga a le patele 
O tlo fiwa nomoro ga go nyakege leina la gagwe 
Ge o na le khahlego o tla bona XXXXXX kapa o fonela V. HLAYISI mo go 0718376207 
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Name Study No. Gender Age Diabetes Characteristics 
(cohort group only). 




Other medication  
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Appendix E: Data collection tests, participant instructions and norms 
 
Test Definition and Norms Participant instruction 
Otoscopy Otoscopy was done to assess outer ear structures. Normal otoscopy was considered as 
visualization of the tympanic membrane with a light reflex (Roeser, Clark, & Mendrygal, 
2011; Sautter & Hirose, 2007). Patients with wax impaction, perforations as well as 
discharging ears were referred for audiological and medical treatment within the facility 
before diagnostic audiometry is administered. 
 
Participants were not expected to give any 
subjective feedback and were asked to allow 




Audiometry was performed to assess the lowest audible threshold across 8 frequencies (0.25 
to 8 kHz) with normal hearing classified as thresholds at or below 15 dB HL with both air and 
bone conduction assessments (Harrell, 2002). The guidelines for manual pure tone 
audiometry were according to the Handbook of Audiology by Katz, (2002) using a 10dB 
decrease and 5dB increase method to search for the absolute threshold (Soer, n.d.) The 
absolute hearing threshold for that specific frequency was defined as the lowest intensity level 
Participants were instructed to press a response 
button when they hear the pure tone sounds 
presented to them.  
Participants were instructed to press the button 
when they hear even the softest sounds. 
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in dB where a person hears a sound 50% of the time. When participants had normal air 
conduction thresholds (< 15 dB HL), no bone conduction was done.  
Severity and Type of hearing loss: Classification norms for hearing loss severity and type of 
loss used were according to Stach, (2008) (see Table1 and Table2). Severity of loss was 
determined with two averages of the pure tone thresholds (PTA).  The first average was the 
low to mid frequency average (0.5, 1 & 2 kHz) and the second a high frequency average (2, 




Otoacoustic emission (OAE) testing was done to assess cochlear  function with objective 
monitoring of the dynamic changes in cochlea  responsiveness before functional and 
significant hearing loss occur (Botelho et al., 2014; Hamed & El-attar, 2010). Distortion 
Product OAEs were assessed and recorded using DPgram charts. DPOAE’s were elicited at 
2f1-f2 between frequencies from 1 kHz to 8 kHz. (Botelho et al., 2014; Hall & Swanepoel, 
2010). The intensities of F1 and F2 will be at 65 dB SPL (L1) and 55 dB SPL (L2), and a 
f2/f1 ratio of 1.22 were used. A DPOAE was regarded as present with a signal to noise ratio 
> 6 dB as well as absolute DPOAE level > 0 dB (Botelho et al., 2014).  
Distortion Product OAE assessment was 
conducted and researcher will place in the 
participant’s ear and participants were asked to 
remain quiet and calm as this test is objective 
and requires no responses from the participant. 
Participants were instructed not chew, swallow 
or speak during this test.  
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Balance The MCTSIB is a static balance assessment that gave information about the sensory 
integration of three main components of balance including somatosensory, visual and 
vestibular (Leddy, Crowner, & EArhart, 2011; Salsabili et al., 2011; Yim-Chiplis & Talbot, 
2000). The MCTSIB was carried out over four conditions which are eyes open and closed 
with foam and firm surface. Participants were timed on how long they maintain balance in 
each condition with the standard at 30 seconds (Leddy et al., 2011). The total score was out 
of 120 seconds for all four conditions and recorded on the relevant score sheet. Timing 
stopped  when the patient opened their eyes and or moved their foot. 
The DGI is a dynamic balance assessment that provided information about dynamic postural 
stability and quantified fall risk (Wrisley et al., 2003). This DGI consisted of 8 tasks with 
varying demands, such as walking at different speeds, ascending and descending stairs, and 
making quick turns. Each item was scored on a 4-level ordinal scale with a maximum possible 
score, on the entire DGI, of 24. A score of 19 or less indicated an increased risk of falling 
(Fujisawa et al., 2007; Leddy et al., 2011; Wrisley et al., 2003).  
Participants were asked to take off their shoes 
and stand upright with eyes open and closed on 
a firm surface and on foam. Researcher then 
recorded the time with a timer in each condition 
(eyes open and closed as well as firm surface 
and foam). Participant’s time scores were 
recorded in the relevant form. Guarding from 
falls was done with a gait belt that was placed 
around the participant’s waist. 
Participants were also asked to walk straight on 
a level surface with various conditions 
including, head turns, going up steps and head 
turns (vertically and horizontally).  
89 
 





















Name: .........................................Study No.......................... Age: ............  Gender:................. .....   































Norms and classifications of hearing loss: 
Table 1.  
Classification of hearing loss Severity for adults (Harrell, 2002) 
Severity classification Decibels (dB HL) 
Slight hearing loss 16-25 dB HL 
mild hearing loss 26-40 dB HL 
moderate hearing loss 41-70 dB HL 
severe hearing loss 71-90 dB HL 
profound hearing loss 90+ dB HL 
Table 2.  
Type of hearing loss and audiological presentation (Katz, 2002) 
Type of Hearing loss Audiological Presentation 
conductive hearing loss bone conduction levels < 15 dB HL  
air conduction > 15 dB HL 
sensorineural hearing loss both bone and air conduction levels > 15 dB HL with < 10 dB 
difference between the levels 
mixed loss hearing loss both bone and air conduction levels > 15 dB HL with > 10 dB 
difference between the levels when masking is applied 
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Appendix G: Modified Clinical Test of Sensory Interaction in Balance Scoring Sheet 
Subject Name: 
Date: 
Participants will be asked to stand with their hands at their sides, feet together and perform the 
following conditions: 
 Stand on firm surface, eyes open
 Stand on firm surface, eyes closed
 Stand on foam surface, eyes open
 Stand on foam surface, eyes closed
The participant’s performance is timed for 30 seconds. Test is terminated when arms or feet 
change position as well as when eyes opened in an eyes closed condition.  
Total score (Modified CTSIB) = 
 Average Time Cond 1 (if > 1 trial required) +
 Average Time Cond 2 (if > 1 trial required) +
 Average Time Cond 3 (if > 1 trial required) +
 Average Time Cond 4 (if > 1 trial required)
TOTAL SCORE: ___/120 sec 
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Appendix H: Dynamic Gait Index Score Sheet 
 
The test can be performed with or without an assistive device. The highest possible score is 24 
points. Tasks involved include: steady state walking, walking with changing speeds, walking 
with head turns both horizontally and vertically, walking while stepping over and around 
obstacles, pivoting while walking as well as stair climbing. Scores are based on a 4-point scale: 
3 = No gait dysfunction, 2 = Minimal impairment, 1 = Moderate impairment, 0 = Severe 
impairment 
1. Gait Level Surface. Score:    
 (3) Normal: Walks 6.1 meters; no assistive devices, good speed, no evidence for imbalance, 
normal gait pattern. 
(2) Mild Impairment: Walks 6 meters; uses assistive device, slower speed, mild gait deviations. 
(1) Moderate Impairment: Walks 6 meters; slow speed, abnormal gait pattern, evidence for 
imbalance. 
(0) Severe Impairment: Cannot walk 6 meters without assistance, severe gait deviations or 
imbalance. 
2. Change in Gait Speed. Score:    
 (3) Normal: Able to smoothly change walking speed without loss of balance or gait deviation. 
Shows a significant difference in walking speeds between normal, fast, and slow speeds. 
(2) Mild Impairment: Is able to change speed but demonstrates mild gait deviations or no gait 
deviations, but unable to achieve a significant change in velocity, or uses an assistive device. 
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(1) Moderate Impairment: Makes only minor adjustments to walking speed, or accomplishes a 
change in speed with significant gait deviations or changes speed but loses balance but is able 
to recover and continue walking. 
(0) Severe Impairment: Cannot change speeds, or loses balance and has to reach for wall or be 
caught. 
3. Gait with Horizontal Head Turns. Score:    
 (3) Normal: Performs head turns smoothly with no change in gait. 
(2) Mild Impairment: Performs head turns smoothly with slight change in gait velocity, i.e., 
minor disruption to smooth gait path or uses walking aid. 
(1) Moderate Impairment: Performs head turns with moderate change in gait velocity, slows 
down, staggers but recovers, can continue to walk. 
(0) Severe Impairment: Performs task with severe disruption of gait, i.e., staggers outside 15” 
path, loses balance, stops, and reaches for wall. 
4. Gait with Vertical Head Turns. Score:    
 (3) Normal: Performs head turns with no change in gait. 
(2) Mild Impairment: Performs task with slight change in gait velocity, i.e., minor disruption 
to smooth gait path or uses walking aid. 
(1) Moderate Impairment: Performs task with moderate change in gait velocity, slows down, 
staggers but recovers, can continue to walk. 
(0) Severe Impairment: Performs task with severe disruption of gait, i.e., staggers outside 15” 
path, loses balance, stops, and reaches for wall. 
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5. Gait and Pivot Turn Score: 
(3) Normal: Pivot turns safely within 3 seconds and stops quickly with no loss of balance.
(2) Mild Impairment: Pivot turns safely in _3 seconds and stops with no loss of balance.
(1) Moderate Impairment: Turns slowly, requires verbal cueing, requires several small steps to
catch balance following turn and stop. 
(0) Severe Impairment: Cannot turn safely, requires assistance to turn and stop.
6. Step over Obstacle. Score: 
(3) Normal: Is able to step over box without changing gait speed; no evidence for imbalance.
(2) Mild Impairment: Is able to step over box, but must slow down and adjust steps to clear
box safely. 
(1) Moderate Impairment: Is able to step over box but must stop, then step over. May require
verbal cueing. 
(0) Severe Impairment: Cannot perform without assistance.
7. Step Around Obstacles. Score: 
(3) Normal: Is able to walk around cones safely without changing gait speed; no evidence of
imbalance. 
(2) Mild Impairment: Is able to step around both cones, but must slow down and adjust steps
to clear cones. 
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(1) Moderate Impairment: Is able to clear cones but must significantly slow speed to 
accomplish task or requires verbal cueing. 
(0) Severe Impairment: Unable to clear cones, walks into one or both cones, or requires 
physical assistance. 
8. Steps    Score:    
(3) Normal: Alternating feet, no rail. 
(2) Mild Impairment: Alternating feet, must use rail. 
(1) Moderate Impairment: Two feet to a stair; must use rail. 
(0) Severe Impairment: Cannot do safely. 
 




Appendix I: Diabetic Neuropathy Symptoms- DNS score 
 
1. Are you suffering of unsteadiness in walking? 
 
Need for visual control, increase in the dark, walk like a drunk man, lack of 
contact with floor 
Remark: it is assumed that the patient has no limiting visual, hearing or central 
neurological deficits.  
 
2. Do you have a burning, aching pain or tenderness at your legs or feet? 
 
3. Do you have prickling sensations at your legs and feet? 
 
Occurring at rest or at night, distal>proximal, stocking glove distribution 
 
4. Do you have places of numbness on your legs or feet? 
 
            Distal>proximal, stocking glove distribution  
 
The questions should be answered "yes" (positive: 1 point) if a symptom occurred more times 
a week during the last 2 weeks or "no" (negative: no point) if it did not. 
Max. score: 4 points 
0 points: PNP absent 
1-4 points: PNP present 
Meijer et al (2003). 
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Participants were asked to stand 6 meters away from the chart and the smallest line they can 
see without corrected vision will be recorded. A pass was when a participant could identify 6/6 
on the chart. This chart was utilised to allow those that cannot read to participate.  
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Appendix K: Ethics Approval, UCT HREC 
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Appendix L: Permission Request Letter to Limpopo Department of Health  
 Division of Communication Science and Disorders  
Department of Health and Rehabilitation Sciences  
Faculty of Health Sciences, F45 Old Main Building  
Groote Schuur Hospital  
Telephone: (021) 406 – 6401, Fax: (021) 406 – 6323  
Email: vera.hlayisi@gmail.com 
 
Dear Sir or Madam 
Re: A study on auditory characteristics and balance functions of diabetic patients 
My name is Vera-Genevey Hlayisi, a student currently conducting a research study as part of 
my MSc Audiology project, investigating the effect of diabetes on hearing and balance. As 
diabetes, hearing loss and balance disorders are public health challenges in South Africa, it is 
hoped that the results of this study will be significant and ultimately provide information that 
could guide the management of diabetic patients. I therefore request permission access patients 
and their medical folders to conduct this research at your clinic.  
The study is aimed at determining the proportion of diabetes patients that present with a hearing 
loss as well as with balance disorders. I plan to assess diabetic patients and review their medical 
folders to ascertain the information I need. There are no risks identified for patients or the 
hospital, as data collection will not hinder their continuation with medical management and 
monitoring of their conditions. I will also be using the audiology consultation room within the 
facility and need no extra space or resources. Furthermore, throughout the data collection I will 
be doing the testing and recording myself therefore no extra duties implied for the staff onsite. 
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I therefore request permission to access patients undergoing diabetes treatment in your clinic 
as well as their medical records to invite them to be part of this study.  
Please find the study proposal attached. For your convenience the consent form is attached.  
You are free to withdraw your consent at any time during the study.  If you need any further 
information, or have any concerns, please do not hesitate to contact the investigator.  If you 
have any queries or concerns regarding this study, please feel free to contact myself or my 
supervisors at the numbers provided below: 
Yours faithfully 
Student Researcher- Hlayisi Vera-Genevey:(0718376207) 
Supervisor- Lebogang Ramma - (021) 406-6954 and 073 153 3803. 
Faculty of Health Sciences Human Research Ethics Committee (to be contacted if there are 
any ethical concerns regarding the study) Prof. Marc Blockman:(021)-406-6626 (Phone) or  




This is to certify that I _______________________ hereby agree to for V. HLAYISI to conduct 
research as part of her Master’s degree with diabetic patients in our facility.  
All the documentation from the University of Cape Town faculty of Health Sciences Human 
Research Ethics Committee regarding ethical clearance for the study has been provided. The 
study and the clinic’s participation in it have been clearly explained in full to me by the 
researcher and I understand all the explanations given to me. I understand all the proceedings 
and requirements for the study from our institution and thereby give my support throughout the 
research time frame. The questions that I asked were answered to my satisfaction. I have 
contacts for the University and the supervisor’s of the researcher should I need to contact them 
at any time. 
 
Name:         Date:     
Signature:      
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Appendix M: DoH Limpopo Approval Letter 
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Appendix N: Information letter 
Division of Communication Science and Disorders 
Department of Health and Rehabilitation Sciences  
Faculty of Health Sciences  
F45 Old Main Building  
Groote Schuur Hospital  
Telephone: (021) 406 – 6401  
Fax: (021) 406 – 6323  
Email: vera.hlayisi@gmail.com  
Hello, my name is Vera-Genevey Hlayisi and I am a student from the University of Cape Town. 
I am doing research as part of my Masters degree on Diabetes and how it affects hearing and 
balance functions. The study seeks to add to the current understanding of hearing loss and 
balance dysfunctions in their association with diabetes and in a South African population. It is 
expected that results of the study will be used to inform clinical practice and management 
practices that could be used to improve the quality of services provided to patients with diabetes 
in South Africa.  
I would like to ask you to be part of this study. 
Before agreeing to join the study, you need to read the following which tells you about why 
the study is important, how the study will work, what you have to do, as well as your rights.  
These include your right to change your mind at any time about being in the study. This 
information is to help you to choose if you would like to join the study. 
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As I student I have to make sure your rights are protected and the study is safe.  This study has 
been approved by the Human Research Ethics Committee of the University of Cape Town 
whose job it is to make sure everything is correct.   
What is the study about? 
I am trying to find out the number of Diabetes patients who have hearing loss and balance 
disorders or both. If you decide to join, you will be tested for your hearing and balance 
functions.   
What will happen to me if I agree to be in the study? 
You will have to sign a form to say you agree to be in the study.  You can talk about this with 
your friends and family if you want to and can come back another day to have the tests. 
I will look in your folder to find out about your medical problems 
You will have hearing and balance tests done. The tests will take 40 minutes to an hour. In the 
hearing tests you will be asked to listen to sounds over earphones and tell me if you hear them. 
There are two more tests where the machine does all the work – I will put a probe in your ear 
and take some measurements.  You can relax during this time.  In the balance tests, you will be 
asked to walk a little, sometimes moving your head, sometime stepping over a box or around 
cones.  Then you will stand for a short time with your eyes open and closed.  I will time to see 
how long you can hold the positions, but it is very quick. I will make a note on all your results.  
I will tell you what all the tests show and what to do if I pick up any problems. 
What do I get out of agreeing? 
There is no payment if you join the study.  We hope that by understanding how Diabetes can 
change hearing and balance we might be able to offer help to patients with these problems 
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 Is there anything I should be worried about if I agree? 
Both the balance and hearing tests have no indicated risks to them and will be carried out by a 
qualified professional.  Should any abnormalities be detected with the balance and hearing 
assessments or any other medical concerns that may be discovered you will be referred for 
further management with the relevant medical professional. You can decide if you want to 
attend or not. 
Do I have to pay for the tests? 
You do not have to pay for the tests in this study.  You will not be paid for doing the tests, you 
are a volunteer. 
Who will know if I join or not? 
All information collected about you during the study will be kept by the researcher and your 
name will be hidden and a number will be used in place of your name. No marks will be put in 
your folder and you will not lose your place in the queue if you agree, you will go back to your 
place when I am finished. 
Do I have to join?  What if I change my mind? 
You can choose not to take part in this study, or if you decide to take part, you can change your 
mind later and that will not be a problem.  Taking part or taking part and changing your mind 
will not change how the doctors and nurses at the clinic treat you. 
Questions: 
For the time of the study you are still under the care of your doctor whom you should contact 
them at any time should you have any concerns. For questions about the study you can contact 
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Dr Lebogang Ramma at any time on the following contact details (021) 406-6954 and 073 
153 380.  
This study was reviewed by the University of Cape Town, Faculty of Health Sciences Human 
Research Ethics Committee. If you have any questions about your rights as a person taking 
part, or if you wish to make a complaint about the study, you may contact Prof. Marc 
Blockman, Chairperson of the Faculty of Health Sciences Human Research Ethics Committee 
at: (021)-406-6626 (Phone) or  Email:  Marc.Blockman@uct.ac.za 
All other questions related to this study can be forwarded to the following individuals: 
Vera-Genevey Hlayisi (Researcher) 0718376207 blyver002@uct.ac.za 





Appendix O: Consent Slip (cohort group) 
Division of Communication Science and Disorders  
Department of Health and Rehabilitation Sciences  
Faculty of Health Sciences, F45 Old Main Building  
Groote Schuur Hospital  
Telephone: (021) 406 – 6401, Fax: (021) 406 – 6323  
Email: vera.hlayisi@gmail.com 
 
Study Title: A study on auditory characteristics and balance functions of diabetic patients 
Consent Slip: 
This is to confirm that I _______________________ agree to volunteer to be part of this study 
and give go-ahead for my patient folder to be reviewed.  The study and my joining in it have 
been clearly explained to me in full to me by the researcher, Vera-Genevey Hlayisi and I 
understand all the explanations given to me. The questions that I asked were answered to my 
liking, and I understand that I can stop and not take part in the study at any time if I wish to do 
so.  
Participant:       Witness: 
I the undersigned have defined and fully explained the study to the above participant. I have 





Appendix P: Consent Slip (control group) 
Division of Communication Science and Disorders  
Department of Health and Rehabilitation Sciences  
Faculty of Health Sciences, F45 Old Main Building  
Groote Schuur Hospital  
Telephone: (021) 406 – 6401, Fax: (021) 406 – 6323 
Email: vera.hlayisi@gmail.com 
Study Title: A study on auditory characteristics and balance functions of diabetic patients 
Consent Slip: 
This is to confirm that I _______________________ agree to volunteer to be part of this study 
as part of the control group.  The study and my joining in it have been clearly explained to me 
in full to me by the researcher, Vera-Genevey Hlayisi and I understand all the explanations 
given to me. The questions that I asked were answered to my liking, and I understand that I can 
stop and not take part in the study at any time if I wish to do so.  
Participant Witness 
I the undersigned have defined and fully explained the study to the above participant. I have 
also answered all questions raised by the participant. 
______________ 
Researcher 
